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Abstract
Since its discovery in 1991, the bacterial periplasmic oxidative folding catalyst DsbA has been the focus of intense
research. Early studies addressed why it is so oxidizing and how it is maintained in its less stable oxidized state.
The crystal structure of Escherichia coli DsbA (EcDsbA) revealed that the oxidizing periplasmic enzyme is a
distant evolutionary cousin of the reducing cytoplasmic enzyme thioredoxin. Recent significant developments
have deepened our understanding of DsbA function, mechanism, and interactions: the structure of the partner
membrane protein EcDsbB, including its complex with EcDsbA, proved a landmark in the field. Studies of DsbA
machineries from bacteria other than E. coli K-12 have highlighted dramatic differences from the model or-
ganism, including a striking divergence in redox parameters and surface features. Several DsbA structures have
provided the first clues to its interaction with substrates, and finally, evidence for a central role of DsbA in
bacterial virulence has been demonstrated in a range of organisms. Here, we review current knowledge on
DsbA, a bacterial periplasmic protein that introduces disulfide bonds into diverse substrate proteins and which
may one day be the target of a new class of anti-virulence drugs to treat bacterial infection. Antioxid. Redox Signal.
14, 1729–1760.
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I. Introduction
The three-dimensional structure of proteins under-pins their function. This in turn means that immature
proteins may not attain activity if they are not folded prop-
erly, and thatmature proteinsmay lose activity prematurely if
they become unfolded, or if the underlying polypeptide chain
is severed through the actions of proteases. Unfolded proteins
also pose a risk of forming toxic aggregates and fibrils (9, 105).
Clearly, it is important for a protein’s survival—and for the
survival of the parent cell and organism—that a protein
reaches its full potential by rapidly and efficiently adopting its
correct fold.
To overcome possible folding problems, cells encode an
assortment of protein factors to help other proteins fold cor-
rectly, or to prevent proteins from unfolding under adverse
conditions such as an increase in temperature (207). For
membrane and secreted proteins that function in the espe-
cially unforgiving extracellular environment, a specialized
post-translational modification, the protein disulfide bond, is
often incorporated to help maintain structure and function.
Disulfide bonds are covalent chemical bonds formed be-
tween sulfurs in thiol groups. In proteins, disulfide bonds are
formed between the sulfurs in side chains of cysteine residues.
The disulfide form of the cysteines is referred to as the oxi-
dized form, and the dithiol form of the cysteines is referred to
as the reduced form. A correctly inserted disulfide bond can
fortify a protein fold—and hence serve to protect protein
function—by providing a structural brace within the poly-
peptide fold (Fig. 1). Disulfide bonds contribute considerably
to the stability of the protein fold, as evidenced by an increase
in melting temperature of the oxidized compared with the
reduced form of the protein (217, 219). Furthermore, disulfide
bonds provide protection against proteolysis (15, 109). Dis-
ulfide bond formationmay also play a regulatory role in some
proteins, by changing the shape of the protein, the surface
charge, or reactivity (202). In this way, the reversible nature of
the disulfide bond can act as a redox signaling mechanism
(38). However, we will not discuss redox signaling here. We
focus specifically on the DsbA oxidative folding catalysts that
catalyze the formation of structural disulfide bonds and
thereby add stability and protease resistance to folding pro-
teins in bacteria.
The importance of disulfide bonds to the function of pro-
teins, and thus to the functioning of cells and organisms, is
perhaps best indicated by the finding that almost all organ-
isms encode proteins to catalyze the process of disulfide bond
formation, reviewed in (91). In the late 1960s, the first oxida-
tive protein folding catalyst was identified: protein disulfide
isomerase (PDI) (65). PDI is a eukaryotic endoplasmic retic-
ulum (ER) protein that introduces disulfide bonds into folding
proteins and shuffles incorrect disulfide bonds in misfolded
proteins. Surprisingly, it was more than 20 years later that the
first bacterial oxidative folding catalyst was discovered in the
early 1990s (12, 123). That protein was DsbA, the topic of this
review. The first DsbA protein identified was from Escherichia
coli and was found to have a signal sequence that localized it
to the bacterial periplasm. DsbA has a somewhat unsophis-
ticated function in comparison with PDI (77), in that it simply
and relatively indiscriminately adds disulfide bonds, via a
disulfide exchange reaction, to cysteine-containing proteins in
the periplasm.
In this comprehensive review, we summarize the rapidly
accumulating body of knowledge on the structure and func-
tion of DsbA. In Section II we begin by reviewing the different
oxidative folding pathways that have been discovered, cov-
ering both eukaryotic and prokaryotic systems. Section III is
FIG. 1. Disulfide bonds add bracing to protein structure.
(A) Schematic representation of an unfolded protein having
little secondary structure and no tertiary structure. (B)
Schematic representation of a folded protein structure that in
(C) is stabilized by disulfide bond formation. In each case,
the polypeptide chain is represented by a black coiled line,
reduced cysteine residues are represented by white circles
with no connecting lines and disulfide bonds between the
cysteines are represented by white circles connected by white
rectangles. (D) The symbols used in figures throughout the
manuscript to denote different states of folding protein
substrates are shown: unfolded, folded without disulfide
bonds, folded with disulfide bonds, and misfolded with in-
correct disulfide bonds.
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devoted to a description of the archetypal EcDsbA fold and
provides a summary of currently available DsbA structures.
Section IV describes variations to the archetypal EcDsbA fold
that have been identified in the structures of DsbA proteins
from different organisms. Section V reviews what is known
about the binding of substrates and other ligands by DsbA.
Finally, in Section VI, we focus on the function of DsbA as a
central mediator of virulence in bacteria. Section VII sum-
marizes briefly the main points and provides perspectives for
future DsbA research.
A. Nomenclature
A few words of explanation are required regarding the
nomenclature we use for DsbA proteins in this review. For
simplicity and clarity, we distinguish DsbA proteins origi-
nating from different bacteria by using the initials of the
bacteria; for example, E. coli DsbA is referred to as EcDsbA.
However, as with all nonstandard abbreviations, we refer to
the full name of the organism in the first instance, followed by
the abbreviation in parentheses [e.g., Staphylococcus aureus
DsbA (SaDsbA)]. Thereafter, we use the abbreviated name
when referring to the specific protein. Where more than one
DsbA is encoded by an organism, we use the names that have
been assigned to each of the proteins, if these have been
published previously. For example, Neisseria meningitidis en-
codes three DsbA proteins, two of which are membrane-
anchored and one of which is soluble (203). These have been
called NmDsbA1, NmDsbA2, and NmDsbA3 (203); we use
this same nomenclature here. Where we make reference to
multiple DsbAs from a single organism for which no names
have been assigned previously, we provide names as well as
the gene coding for each of the specific encoded proteins so
that it is clear to which protein we refer.
For figures throughout the article, we use a set of consistent,
specific symbols to denote unfolded proteins, folded proteins,
folded proteins with correct disulfide bonds, and misfolded
proteins with incorrect disulfides (Fig. 1D).
II. Oxidative Protein Folding Pathways
The ability of proteins to fold into their correct three-di-
mensional structures is vital for cell growth and survival (47).
Due to their existence in crowded cellular compartments,
nascent polypeptides exposing hydrophobic surfaces are
prone to aggregation and in turn misfolding. To overcome
this obstacle, a complex machinery of molecular chaperones
exists to ensure efficient transport and folding of newly syn-
thesized proteins (83, 226). There are also pathways involving
oxidative folding steps present in a range of cellular com-
partments (e.g., the periplasm in Gram-negative bacteria, and
the mitochondria and ER in eukaryotes).
The function of oxidative protein folding pathways is to
form disulfide bonds in substrate proteins. Formation of a
disulfide bond is a reversible reaction in which the thiol
groups of two cysteine residues on the folding protein are
oxidized to form a covalent sulfur–sulfur bond. Therefore,
oxidative protein folding generally occurs in a cellular com-
partment separated from the reducing environment of the
cytosol where protein synthesis occurs. Disulfide bond for-
mation adds stability to exported and secreted proteins, in-
cluding membrane proteins, to enable them to withstand the
relatively hostile extracellular environment (171).
Oxidative protein folding pathways have been character-
ized in a number of eukaryotic and prokaryotic cellular
compartments. The eukaryotic pathways will be discussed
briefly first, so as to illustrate the relationship to the bacterial
periplasmic disulfide bond (Dsb) family of proteins. Then we
summarize the DsbA–DsbB oxidative folding pathway and
the DsbC–DsbD isomerization pathway, from the model or-
ganism E. coli K-12, before briefly reviewing pathways that
have evolved in other bacteria.
We note that selenocysteine (SeCys) containing DsbA-like
protein sequences have been identified from the genomes of
prokaryotes and lower order eukaryotes (66, 117, 220, 231–
233). SeCys residues in proteins can give rise to unique
properties in comparison to cysteine-containing variants (3).
Furthermore, simple diselenides, but not analagous dis-
ulfides, at concentrations approaching catalytic levels can
functionally replace DsbA in vivo in dsbA knockouts (16).
However the products of SeCys dsbA-like genes have not yet
been characterized. Therefore, we will not consider these
proteins further in this review. However we, and no doubt
many other researchers in this field, are very interested to
learn more about the structure and function of this new class
of DsbA proteins.
A. Eukaryotic pathways
In contrast to a prokaryotic cell in which the periplasmic
space is typically the only cellular compartment separated
from the cytoplasm, a eukaryotic cell has a variety of organ-
elles in which oxidative protein folding can occur. Indeed,
oxidative protein folding has been identified in the ER, the
mitochondria, and in plant chloroplasts. The mechanism of
oxidative protein folding in chloroplasts remains largely un-
characterized so this will not be discussed here; instead we
refer the reader to Ref. 113. The oxidative protein folding
pathway of the ER is unique in that this organelle is respon-
sible for folding and transporting proteins that are targeted to
other locations, whereas mitochondria and chloroplast path-
ways are specific to proteins that remain within those
organelles.
For a comprehensive and critical review of ER oxidative
protein folding, we refer the reader to Ref. 84. The oxidative
protein folding pathway in yeast ER involves two proteins:
protein disulfide isomerase (PDI) and a sulfhydryl oxidase
(Fig. 2A). The two sulfhydryl oxidase enzymes found in yeast
are ER oxidoreductin (Ero1p) and a protein termed ‘‘essential
for respiration and vegetative growth’’ (Erv2p) (60, 61, 144,
172). PDI was one of the first identified thiol–disulfide oxi-
doreductases (70), and there are now at least 20 members of
this family in humans (84) and five in yeast (188), each of
which is characterized by localization to the ER, and the
presence of at least one Thioredoxin-like domain. Individual
PDI family members may have tight substrate specificity,
suggesting that the wide variety of PDI-like proteins in the
ER is necessary to allow folding of a broad range of protein
targets (115).
PDI is thought to catalyze several redox reactions, includ-
ing oxidation, reduction, and isomerization (124, 186). Oxi-
dized PDI becomes reduced when it acts as a disulfide donor
in the oxidative folding of substrates (Fig. 2A). Reduced PDI
can then function as an isomerase to shuffle incorrectly-
formed disulfide bonds in substrates, or it can be re-oxidized
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by the membrane-associated protein Ero1p or the second
sulfhydryl oxidase Erv2p in yeast. Ero1p and Erv2p utilize
molecular oxygen, coupledwith a flavin adenine dinucleotide
(FAD) cofactor to generate disulfide bonds, which are trans-
ferred to PDI (61, 75, 76). The major ER oxidase, Ero1p, does
not share obvious sequence similarity with Erv2p, however
the two proteins do share a core four-helix bundle architecture
surrounding the FAD cofactor (Fig. 2A) and both require two
redox-active cysteine pairs for activity (62, 74, 76).
The discovery of the mitochondrial machinery for import
and assembly (MIA pathway) in the intermembrane space
(IMS) of mitochondria was a major breakthrough in the field
of oxidative protein folding (29, 156). For a detailed descrip-
tion we refer the reader to several excellent reviews (44, 55,
193). The essential MIA pathway comprises Mia40 and the
FAD-dependent sulfhydryl oxidase Erv1 (87, 156, 198). Only
reduced and unfolded precursors can pass through the
translocase of the outer membrane (TOM) complex, so that
oxidation of free thiols by Mia40 traps newly imported pro-
teins in the IMS, and therefore contributes to the directionality
of the MIA pathway (Fig. 2B).
Mia40 proteins have a divergent N-terminal domain and a
conserved C-terminal domain of approximately 60 amino
acids, containing six invariant cysteine residues (29, 201).
These six cysteines comprise a signature motif: CPC–CX9C–
CX9C. Curiously, the twin CX9C motif resembles that of
many Mia40 substrates; an alternative twin CX3C motif has
also been identified in some Mia40 substrates (145). Re-
cently, the NMR structure of human Mia40 (10) and crystal
structure of yeast Mia40 (fused to maltose binding protein)
(128) were reported. These structures confirm that the con-
served domain contains the helix–loop–helix organization of
the structurally characterized twin CX9C proteins. Im-
portantly, the structures show that Mia40 is not related to
thioredoxin, unlike many other oxidative folding proteins.
Additionally, the Mia40 structures reveal a hydrophobic
region on the Mia40 surface proposed to be involved in
substrate binding.
In the IMS, Erv1maintainsMia40 in the oxidized state. Erv1
is structurally similar to the Ero1p and Erv2p proteins asso-
ciated with PDI oxidation in the ER (180) and to the integral
inner membrane protein, DsbB, of the bacterial pathway (187)
(see Section IIB). The FAD domain of Erv1 can interact with
cytochrome c, thereby coupling Erv1 directly to the respira-
tory chain, leading eventually to the production of water. This
coupling prevents the formation of H2O2, and makes re-
oxidation of Mia40 very efficient, even at low oxygen con-
centrations (19, 39).
B. The classical bacterial dithiol oxidizing pathway:
DsbA and DsbB
The bacterial oxidative protein folding pathway was first
characterized, and is also best characterized, for E. coli K-12.
This organism is therefore often used as the archetype for
bacterial oxidative protein folding. The oxidative pathway of
E. coli K-12 involves two proteins, E. coli DsbA (EcDsbA) and
E. coli DsbB (EcDsbB), acting together to introduce disulfide
bonds into folding protein substrates (110) (Fig. 3A). EcDsbA
is the key player (12) because it interacts directly with folding
protein substrates and transfers its disulfide to them. With a
redox-potential of 122mV (100), it is a highly oxidizing
protein, though as we will see below, other more recently
characterized DsbA proteins are even stronger oxidants. After
a disulfide transfer reaction with a folding protein, EcDsbA
becomes reduced. The second protein, EcDsbB, reoxidizes
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FIG. 2. The oxidative protein folding machinery of the
endoplasmic reticulum and of the mitochondria. (A) Oxi-
dized PDI serves as a disulfide donor for reduced substrate
proteins. Reduced PDI can also shuffle incorrectly formed
disulfide bonds (isomerization). Reduced PDI is in turn re-
oxidized by Ero1p (or Erv2p) in yeast to complete the cycle.
(B) In mitochondria, Mia40 serves as a receptor that directly
interacts with twin CX3C or twin CX9C proteins which enter
the intermembrane space (IMS) through the TOM complex.
During the import reaction, Mia40 forms a transient mixed
disulfide with the substrate as it exits the TOM pore (1).
Importantly, formation of the complex blocks reverse trans-
port of small unfolded cysteine containing proteins, trapping
them in the IMS. Erv1 interacts with this complex forming a
ternary complex (197) (2). Reduced Mia40 is then re-oxidized
by Erv1 to complete the cycle (3).
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reduced EcDsbA so that EcDsbA is able to catalyze further
oxidative folding reactions (177) (Fig. 3A).
The active site of EcDsbA comprises the classic thioredoxin
CXXC motif, encompassing two redox-active cysteines. The
specific motif in the case of EcDsbA is Cys30–Pro31–His32–
Cys33 (CPHC). The highly oxidizing nature of the EcDsbA
active site is unusual for a disulfide and originates from the
surprisingly low pKa of approximately 3.5 of the more N-
terminal Cys (Cys30) in the CXXC motif (72, 163, 223, 229).
This exceedingly low pKa means that in the reduced form at
physiological pH, the Cys30 residue of EcDsbA exists in the
thiolate anion form. Unusually for proteins, the reduced
dithiol form of EcDsbA is more stable than the oxidized
disulfide-bonded form of the enzyme by 3.6 1.4 kcal=mol
(229). This energetic difference between the oxidized and re-
duced forms of the active site drives disulfide transfer by
EcDsbA and thus results in oxidation of its substrates. Stabi-
lization of the reduced form over the oxidized form is thought
to occur via a network of interactions with the Cys30 thiolate
side chain of EcDsbA (see Section III E below) (79).
The disulfide exchange reaction catalyzed by EcDsbA is a
bimolecular nucleophilic substitution reaction (SN2) (56, 213).
Similar to other proteins with a catalytic Thioredoxin fold,
thiol–disulfide exchange by EcDsbA is thought to proceed via
two steps (64, 119) (Fig. 4). The reaction begins with nucleo-
philic attack on the surface exposed Cys30 sulfur of oxidized
EcDsbA by a cysteine from the reduced substrate protein,
resulting in the formation of a mixed disulfide intermediate
between the substrate and EcDsbA. In the second step, an-
other substrate cysteine attacks the substrate sulfur partici-
pating in the mixed disulfide. The result of this second
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FIG. 3. The oxidative and isomerization pathways in E. coli K-12. (A) Oxidized EcDsbA transfers its active site disulfide to
an unfolded protein substrate; the substrate cysteines are thus oxidized, and the protein becomes folded. The active site
cysteines C30 and C33 of EcDsbA become reduced and are re-oxidized by C104 and C130 of EcDsbB. This cycle is repeated to
maintain EcDsbA in the active oxidized form. Ubiquinone (UQ) is the recipient of electrons from EcDsbA and oxidizes
EcDsbB under aerobic conditions. Alternatively, menaquinone (MK) can oxidize EcDsbB under anaerobic conditions. (B)
When EcDsbA catalyzes incorrect disulfide bond formation in substrates, EcDsbC proofreads and shuffles the disulfide bonds
until the correct connections are made. After introducing disulfides into the substrate, EcDsbC becomes oxidized. The
disulfide at the active site of EcDsbC is reduced by the N-terminal domain of EcDsbD (nDsbD for N-terminal domain of
DsbD) so that EcDsbC is converted into the active reduced form. The other two domains of EcDsbB are labeled c and t for the
C-terminal and transmembrane domains, respectively.
EcDsbAox EcDsbAint EcDsbAred
CPHC CPHC CPHC
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FIG. 4. EcDsbA catalyzed disulfide transfer. The reaction
(left panel) begins with nucleophilic attack from a substrate
protein on the surface exposed N-terminal cysteine (Cys30)
of the disulfide bond formed at the CXXC active site of
EcDsbA (1). This attack results in an intermediate mixed
disulfide complex between EcDsbA and the substrate protein
(center panel), which in turn is reduced by nucleophilic attack
of another substrate thiolate (2), leaving the substrate oxi-
dized and EcDsbA reduced (right panel). The reaction pro-
ceeds as a bimolecular nucleophilic substitution reaction.
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reaction is the formation of a disulfide bond in the substrate
(oxidized substrate) and production of reduced EcDsbA. To
complete the catalytic cycle, EcDsbB then re-oxidizes reduced
EcDsbA.
The discovery that EcDsbA acts by transferring its disulfide
bond to folding proteins, and as a result becomes reduced, led
to the question of how EcDsbA is re-oxidized in the bacterial
periplasm.Mutational analysis identified a second gene, dsbB,
which encodes a protein that oxidizes reduced EcDsbA (11,
159). The EcDsbB protein is located in the bacterial inner
membrane between the cytoplasm and the periplasm and
possesses four transmembrane helices connected by two
periplasmic domains (114, 234) (Fig. 5). The four-helix topol-
ogy of EcDsbB is reminiscent of the eukaryotic counterparts
Erv2p and Ero1p, though Erv2p and Ero1p are soluble rather
than membrane embedded.
EcDsbB contains four essential cysteine residues (118) in
two periplasmic loops (114): Cys41 and Cys44 in the more N-
terminal periplasmic loop (P1) and Cys104 and Cys130 in the
more C-terminal periplasmic loop (P2) (131). Experiments
with a Cys33 mutant of EcDsbA led to the accumulation of a
disulfide-linked complex between EcDsbA and EcDsbB (81,
130), indicating that the surface exposed Cys30 of EcDsbA
interacts with Cys104 of EcDsbB to form the mixed disulfide.
Electrons from EcDsbA are presumed to flow first from
EcDsbA to Cys104–Cys130 of EcDsbB and from there to
EcDsbB Cys41–Cys44, and then finally to quinones and the
respiratory chain (6, 43, 200). The quinone cofactor of EcDsbB
is ubiquinone (UQ) in the aerobic oxidative folding cycle and
menaquinone (MK) in the anaerobic oxidative folding cycle
(6); quinone binding is essential for the EcDsbA oxidizing
function of EcDsbB (71). Mutagenesis and kinetics data from
Kadokura and Beckwith (118) and Tapley et al. (200) had
suggested that the oxidation of EcDsbA by EcDsbB occurs
through a series of highly concerted disulfide exchange re-
actions. This idea is strongly supported by the structural
model of the EcDsbB:EcDsbA inter-loop complex (generated
from NMR data of EcDsbB and of the EcDsbB interaction
with the EcDsbA, as well as the crystal structure of EcDsbB:
EcDsbA) that reveals a neat straight-line arrangement of the
six redox-active cysteines (234).
EcDsbB has strict binding specificity for EcDsbA and does
not directly interact with the reduced folding protein sub-
strates of EcDsbA. The standard redox potential values for the
EcDsbB cysteine pairs are much lower than that of EcDsbA
(–210mV forCys41–Cys44 and220mV forCys104–Cys130 of
EcDsbB comparedwith122mV for Cys30–Cys33 of EcDsbA)
(100, 106). Characterization of EcDsbB in the oxidative path-
way revealed that the second periplasmic loop, encompassing
Cys104 and Cys130, undergoes considerable conformational
changes during the enzymatic reaction, induced by EcDsbA,
and that these changes and consequent disulfide rearrange-
ments may facilitate the energetically unfavorable electron
transfer from EcDsbA to EcDsbB (107, 118, 200).
C. The classical bacterial disulfide
isomerization pathway
When protein substrates with multiple cysteines are being
folded, the oxidative system of EcDsbA and EcDsbB can pair
cysteine residues in combinations that are not present in the
native structure, trapping the proteins in a non-native con-
formation. Consequently, E. coli K-12 has evolved a pathway
for disulfide isomerization, to ensure the formation of correct,
native disulfide bonds (Fig. 3B). This system is comprised of
two proteins, EcDsbC and EcDsbD, which proofread and re-
shuffle non-native disulfides to aid correct oxidative protein
folding. The soluble periplasmic protein EcDsbCmediates the
isomerization of disulfide bonds in substrate proteins (17) and
it also possesses chaperone activity (31). The second compo-
nent of the isomerization pathway is EcDsbD, an integral
membrane protein that transfers electrons to EcDsbC to
maintain the isomerase in the catalytically active reduced
form (181). Thus, EcDsbC and EcDsbD in this classical bac-
terial disulfide isomerizing pathway are the counterparts to
EcDsbA and EcDsbB of the classical bacterial dithiol oxidizing
pathway.
The crystal structure of EcDsbC reveals a V-shaped
homodimer in which two subunits (223 kDa) are linked at
the base of the V by an N-terminal dimerization domain and
the two catalytic Thioredoxin domains are located at the ends
of the arms (153). The CXXCmotifs of the Thioredoxin fold in
the dimeric EcDsbC have the sequence Cys98–Gly99–Tyr100–
Cys101. In the DsbC crystal structure, these two active sites
face each other on the inside of the V-cleft (153). Dimerization
is essential for the activity of EcDsbC; it protects the enzyme
from being oxidized by EcDsbB (7), thus preventing a futile
electron cycle, and it also generates a molecular cleft lined
with hydrophobic residues that is required for substrate
binding (4, 153). This cleft is necessary for both isomerase and
chaperone activities (7). A recent report showed that it is not
necessary for both catalytic domains of EcDsbC to be present
for disulfide shuffling to occur in E. coliK-12; just one catalytic
active site motif and a substrate binding region are sufficient
for the reaction to proceed (4). However, this work also
showed that engineered EcDsbC variants lacking one of the
catalytic domains were susceptible to oxidation by EcDsbB
(4).
In the periplasm of E. coli K-12 is also found an EcDsbC
homologue called EcDsbG. Like EcDsbC, this protein is a
homodimer (227 kDa) with disulfide bond isomerase and
N C
41
104
44
130
Q
P1 P2P2 l
Periplasm
Cytoplasm
FIG. 5. Topology of EcDsbB. The topology of EcDsbB in
the inner bacterial membrane is shown with the four con-
served cysteine residues represented as gray spheres, indi-
cating the corresponding residue numbers. The quinone is
shown as a hexagon labeled Q. Periplasmic loops P1, P2’,
and P2 as well as N and C-termini are indicated.
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molecular chaperone activity (18, 189). EcDsbG and EcDsbC
share 24% sequence identity, though EcDsbG is expressed at
lower levels than EcDsbC, and exhibits a more narrow sub-
strate specificity (18). For example, unlike EcDsbC, EcDsbG
does not catalyze the reduction of insulin or the oxidative
refolding of RNase (18) (these assays are typically used to
characterize the redox activity of Thioredoxin fold proteins).
The crystal structure of EcDsbG reveals a similar three-
dimensional architecture to that of EcDsbC; thus, the enzyme
is V-shaped and each arm of the V comprises an N-terminal
dimerization domain linked by an a-helix to a C-terminal
Thioredoxin fold catalytic domain (89). Each catalytic domain
of EcDsbG contains the characteristic CXXC redox center (in
this case Cys109–Pro110–Tyr111–Cys112), and these both face
the inside of the V-cleft. As with EcDsbC, the two redox
centers are kept in the reduced form by the membrane protein
EcDsbD (18). Despite the overall structural and topological
similarities between EcDsbG and EcDsbC, there are some
striking differences between the two paralogues. For example,
the dimensions of the V-cleft aremuch larger in EcDsbG and it
contains many acidic residues that generate distinct nega-
tively charged regions (89), which are absent in EcDsbC.
These properties could indicate that EcDsbG preferentially
binds large folded or partially folded substrates (89). For
several years, the functional role in E. coli K-12 of this second
isomerase-like protein EcDsbG remained unknown because
attempts to identify in vivo substrates for this protein had been
unsuccessful. However, a recent elegant study by Depuydt
and co-workers showed that EcDsbG principally interacts
with three L,D-transpeptidases, YbiS, ErfK, and YnhG (45),
which catalyze the cross-linking of peptidoglycan in the
bacterial cell wall. These three proteins each incorporate a
single cysteine, which is required for their activity (148). De-
puydt et al. discovered that both EcDsbC and EcDsbG protect
this cysteine from oxidation to sulfenic acid (45). They also
reported that EcDsbG, which has surface properties better
suited for interacting with folded proteins, is much more ef-
ficient in protecting these folded substrates from cysteine
sulfenylation than EcDsbC (45), which is presumably better
suited to interacting with unfolded or mis-folded substrates.
In the oxidative environment of the periplasm, both
EcDsbC and EcDsbG are maintained in their active reduced
form via interaction with EcDsbD (181). This 59 kDa enzyme
comprises three domains, an N-terminal periplasmic domain
(nDsbD) which has an immunoglobulin-like fold (82), a
transmembrane domain (tDsbD) consisting of eight trans-
membrane helices (32), and a C-terminal periplasmic domain
comprising a Thioredoxin fold with a CXXC motif (cDsbD)
(183). EcDsbD obtains its reducing power from cytoplasmic
NADPH. The flow of electrons is via thioredoxin reductase,
which reduces thioredoxin, and thioredoxin in turn reduces
EcDsbD (electrons are transferred from tDsbD, to cDsbD and
then to nDsbD); EcDsbD ultimately reduces the two isomer-
ase proteins EcDsbC and EcDsbG (32, 126). A disulfide ex-
change cascade mediates all the electron transfer reactions in
this system. Analysis of the redox potentials of the proteins
involved in the cascade indicates that this process is thermo-
dynamically favored, as reviewed in Ref. 120. It is interesting
to note that the EcDsbD membrane-bound domain tDsbD,
which contains only one cysteine pair, is capable of transfer-
ring electrons from cytoplasmic thioredoxin to periplasmic
cDsbD (126). Although there is evidence that these cysteines
are accessible from either side of the membrane (127),
the precise mechanism of how this occurs remains to be
determined.
D. Alternatives to the classical oxidative protein
folding pathway
Oxidative protein folding pathways in bacteria other than
E. coli K-12 have been the focus of considerable recent re-
search. Bioinformatic screening of DsbA homologues (49, 92)
has revealed that DsbA proteins are present in many, but not
all, bacterial classes and show that some bacteria encodemore
than one DsbA homologue. The results of these analyses
suggest that within the bacterial kingdom a number of alter-
nate oxidative protein folding pathways exist, reviewed in
Ref. 92. Some prokaryotes contain multiple DsbA proteins
that likely perform specific oxidative folding roles within the
bacterium. Structures of multiple DsbAs from representative
species are now available and are discussed in detail in Sec-
tion IV. Additionally, some organisms appear to encode only
a single member of the oxidative pathway—for example, S.
aureus (92) and Staphylococcus epidermidis (49) encode only a
DsbA and Helicobacter pylori encodes only a DsbB (49). These
specific organisms may rely on environmental redox condi-
tions to regulate oxidative protein folding.
A recent bioinformatic and functional study by Daniels
et al. (42) has examined disulfide bond formation in Gram-
positive bacteria, which lack an outer membrane, and there-
fore do not possess the protected periplasmic compartment
where oxidative protein folding occurs in Gram-negative
bacteria. The cysteine incorporation patterns were analyzed
for different types of proteins from both Gram-positive and
Gram-negative organisms. In agreement with a previous
study (49), Daniels et al. identified that of the two major phyla
of Gram-positive bacteria, Actinobacteria and Firmicutes,
oxidative protein folding is only likely to occur in the first.
Indeed, their evidence suggests that Firmicutes exclude cys-
teine residues fromprotein sequences to compensate for a lack
of disulfide folding machinery. To support the observation
that disulfide bonds are formed in substrate proteins of Ac-
tinobacteria, Daniels et al. also identified and characterized
three putative secreted soluble Dsb-like proteins with CXXC
motifs (42). They concluded that Actinobacteria encode a
DsbA-like homolog that may exist as a homodimer and
function to oxidize exported substrates. However, as this
species does not encode a DsbB protein, it is unclear how this
DsbA-like protein might be re-oxidized in vivo.
One possible explanation is that such DsbA-like proteins
could be re-oxidized by the bacterial homolog of the eu-
karyotic membrane enzyme vitamin K epoxide reductase
(VKOR) (49). Experiments involving a VKOR homologue
present in Mycobacterium tuberculosis H37Rv illustrates how
re-oxidation may occur in Actinobacteria (49). M. tuberculosis
VKOR (MtbVKOR) was found to restore disulfide bond for-
mation in an E. coli dsbB mutant. This complementation of
EcDsbB activity depended on the presence of EcdsbA, indi-
cating that MtbVKOR does not oxidize folding substrate
proteins itself, but apparently functions in a manner analo-
gous to EcDsbB (49). Therefore VKOR likely re-oxidizes
DsbA-like redox proteins in prokaryotic organisms that re-
quire disulfide bonds in substrate proteins, and may take the
place of DsbB in organisms that do not encode a DsbB protein.
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Furthermore, Dutton and co-workers showed that in vivo
oxidation of EcDsbAwas promotedwhen expression levels of
MtbVKOR in E. coli were increased (50).
Further investigation into the bacterial homologues of
VKOR has revealed that in some species a single polypeptide
chain incorporates both a VKOR and a DsbA-like enzyme.
The crystal structure of one such natural fusion protein from
Synechococcus spp. was recently reported (142). The VKOR
domain within this structure shares some surprising similar-
ities with the structure of EcDsbB. For instance, the catalytic
core of the VKOR membrane domain incorporates a four-
helix bundle architecture that binds a quinone. A cysteine is
located in the VKOR structure on one side of the quinone ring,
a geometry that likely facilitates electron transfer to the aro-
matic systems and which has been observed for the soluble
eukaryotic FAD-containing thiol oxidases Ero1p (74), Erv2p
(76), and Erv1 (221) described above. Furthermore,MtbVKOR
shares many features with human VKOR: both use similar
substrates; both are inhibited by warfarin (whereas EcDsbB is
unaffected), and warfarin-resistant mutations are located in
similar regions in both proteins (50). The key role of
MtbVKOR in M. tuberculosis pathology and the finding
that MtbVKOR can be inhibited by warfarin highlights the
possibility of targeting MtbVKOR for the development
of new therapeutics to treat tuberculosis, or potential new
anticoagulants (50).
The DsbA-like domain in the structurally characterized
VKOR-DsbA fusion incorporates a CPHC catalytic active site,
like that found in EcDsbA. However, the domain is smaller
than EcDsbA and more like thioredoxin (*100 residues) and
it lacks the EcDsbA surface features that interact with EcDsbB
(see Section IIB above). Presumably these features are not
necessary in the fused complex because of the high local
concentration of the two components.
Extensive bioinformatic analyses of Dsb proteins have also
identified that some bacterial species exhibit an unusually
high number of unpaired cysteines in their secreted proteins
compared to E. coli (49). These species were in turn predicted
to have reducing periplasms or lack disulfide bond formation
altogether. The bacteria of one such phylum, Chlamydiales,
all encode dsbA homologs (49, 92), and express a disulfide
bonded major outer membrane protein (225). However, the
identification and characterization of a periplasmic reductase,
DsbH, from Chlamydia pneumoniae TW183 suggests that these
obligate intracellular bacteria may actively reduce proteins in
the periplasm, and therefore use an alternate mechanism for
oxidative protein folding for their limited number of pre-
dicted substrates (146). Further support for this conclusion
comes from a recent study on Bacteroides fragilis (191). In
contrast to C. pneumoniae, B. fragilis encodes neither dsbA nor
dsbB homologs (49, 92). Structural and functional character-
ization of a periplasmic thioredoxin-like protein, TrxP, from
B. fragilis revealed that this organism, like C. pneumoniae,
maintains a reduced cell envelope by expressing a periplasmic
reductase (191).
III. Structure of the Archetypal DsbA
The first structural details of bacterial oxidative folding
pathways were revealed with the determination of the
EcDsbA crystal structure in the early 1990s (Fig. 6) (2, 151).
Prior to the report of the EcDsbA crystal structure, predictions
of the DsbA three-dimensional structure utilized primary
sequence and secondary structure data. This information was
used to suggest that EcDsbA would have a fold similar to
thioredoxin, and was likely to be structurally similar to the N-
terminal thioredoxin-like domain of PDI (53). Although the
prediction of a Thioredoxin fold turned out to be correct, the
overall sequence alignment and secondary structure as-
signment proved inaccurate because the EcDsbA struc-
ture includes an a-helical domain insertion compared to the
canonical Thioredoxin protein fold. Structure determination
of EcDsbA was not trivial. It was crucial to maintain the
protein in the oxidized state to form crystals suitable for dif-
fraction studies and the structure was only elucidated by a
combination of multiple isomorphous replacement and sele-
nomethionine multi-wavelength anomalous diffraction (Se-
Met MAD) phasing methods (151, 152). The structure of
EcDsbA was one of the first to be solved using SeMet MAD
methods.
The E. coli K-12 DSB pathway remains the best character-
ized bacterial oxidative protein-folding system to date. As
such, the 21 kDa EcDsbA protein is regarded as the archetypal
member of the bacterial DsbA family. The structure of EcDs-
bA reveals a protein with a core consisting of a five-stranded
twisted b-sheet, sandwiched between a-helices (Fig. 6). Pfam
classification places EcDsbA into the family PF01323 (57). This
family now consists of more than 3400 sequences and greater
than 25 domain architectures. In addition, structurally char-
acterized DsbA proteins have been grouped into the a and b
(a=b) protein class according to the structural classification of
FIG. 6. Structure of EcDsbA. Ribbon diagram of EcDsbA
(from PDB 1FVK (80)). The sulfur atoms of the catalytic
cysteines are shown as spheres.
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proteins (SCOP) database (162). This classification is based on
hierarchical levels that embody the evolutionary and struc-
tural relationships of proteins. Therefore, proteins with lower
sequence identity but whose structures share similar topolo-
gies are placed into the same class. Due to the fact that
EcDsbA contains a fold similar to the previously character-
ized thioredoxin, EcDsbA belongs to the Thioredoxin-like
superfamily in the SCOP database. However, as a result of the
large a-helical domain insertion into the Thioredoxin fold
(located above the b sheet in the orientation shown in Fig. 6),
EcDsbA and similar proteins have been classified into the
DsbA-like family in the SCOP database.
Recently, there has been a rapid growth in the number of
reported DsbA structures from species other than E. coli.
Through comparative structural biology, this collection of
DsbA structures has the potential to greatly enhance our un-
derstanding of bacterial oxidative protein folding pathways.
Beginning with the report of the Haemophilus influenzae ge-
nome, the advent of genomic sequencing projects at the end of
the last century have had an astonishing affect on the field of
structural biology (58). In regards to bacterial oxidative fold-
ing, these sequencing projects have led to the study and
characterization of an ever-increasing number of important
bacterial species. In the past 5 years alone, the number of
unique DsbA structures from different bacterial species has
grown from two to seventeen (Table 1). It is now evident that
although sequence identity across DsbA proteins from dif-
ferent species is often relatively low, the structural architec-
ture first described for the EcDsbA structure serves as a
valuable reference when attempting to decipher the structure-
function relationship of a new DsbA.
A. The Thioredoxin fold
As previously mentioned, the DsbA proteins structurally
characterized to date are all classified as members of the
Thioredoxin-like superfamily of a=b proteins in the SCOP
database. The Thioredoxin-like superfamily is currently fur-
ther divided into 23 families, some with multiple subfamilies,
based on additions to the Thioredoxin fold. The Thioredoxin
fold is the core structural element of this superfamily (Fig.
7A), which is common to numerous proteins across different
organisms. This fold, named after the protein in which it was
first observed, is a distinct structural motif, and encompasses
the majority but not all of the secondary structure features of
E. coli thioredoxin (98, 125, 150) (Fig. 7B). Publication of two
glutaredoxin structures later revealed that compared with
thioredoxin, the shorter glutaredoxin actually incorporates all
the features of the Thioredoxin fold (52, 224); thus the sec-
ondary structure features of glutaredoxin and the Thior-
edoxin fold are virtually equivalent.
The Thioredoxin fold has been described as having two
folding units (51). The N-terminal motif consists of a b=a=b
structural unit connected by a loop of residues containing an
a-helix to a C-terminal motif comprising b=b=a elements (Fig.
7A). The two b-strands of the N-terminal structural unit are
parallel to one another, whereas the two b-strands of the C-
terminal motif run antiparallel to each other. Therefore, the
b-sheet formed by these structural elements in the Thior-
edoxin fold forms a mixed b-sheet. The b-sheet forms the core
of the Thioredoxin fold and is twisted relative to a central axis
perpendicular to the b-sheet. Furthermore, the b-sheet is
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sandwiched between the three a-helices of the fold. The a-
helices of the N- and C-terminal folding units are arranged in
parallel on one face of the b-sheet, and the a-helix that con-
nects the two folding motifs runs along the opposite face of
the b-sheet, and perpendicular to the other two helices (Fig.
7A). Although the Thioredoxin fold was initially identified
and is present in many redox active proteins, nature has also
used this fold to engineer proteins for a range of other bio-
logical tasks. For instance, it has been incorporated into the
metal binding protein calsequestrin (216), which binds and
releases Ca2þ ions during the muscle contraction-relaxation
cycle, and in the E. coli protein, HyaE, responsible for binding
to the arginine rich Tat signal peptide that regulates hydrog-
enase complex assembly and export (165).
Despite these findings, the majority of proteins with a
Thioredoxin fold also incorporate the redox-active CXXC
catalytic motif at the N-terminal end of the first a-helix of the
Thioredoxin fold (Fig. 7). This motif is critical for redox ac-
tivity in Thioredoxin fold proteins. It has also been shown that
two residues located in the loop connecting the a2-helix and
b3-strand (loop between a6-helix and b4-strand in EcDsbA) of
the Thioredoxin fold are also important for the proper func-
tion, stability, and folding (30, 69, 129) of this family of pro-
teins. This loop contains an isoleucine=valine=threonine
residue followed by a proline residue in the cis conformation
(cisPro). Although this cisPro loop is distant in sequence, it lies
adjacent to the CXXC active site in the folded oxidoreductase.
The crystal structure of EcDsbA also revealed a feature
termed the hydrophobic groove (Fig. 8A) (151). This hydro-
phobic groove is located below the active site cysteines when
viewed in the orientation presented in Figure 6. It is composed
of a number of aromatic (Phe36, Phe174, Tyr178) and aliphatic
CN
N C
N-terminal motif C-terminal motif
b2 a1 b1 b3 b4 a3
a2
Connecting helix
A  Thioredoxin Fold
B  Thioredoxin
C  EcDsbA
b2 a1 b5b3 b4
a3
a2 a4
b1
CGPC
cisPro
cisPro
cisPro
CXXC
C
N
b3
a6
a5 a1a2a3a4 a7
b5
b4b2 b1
310
CPHC
FIG. 7. The Thioredoxin fold and the classical DsbA fold. (A) The structural elements of the Thioredoxin fold are
illustrated in gray. (B) The topology of the E. coli thioredoxin A structure is shown with elements of the Thioredoxin fold in
gray and additional features in white. (C) The topology of EcDsbA is shown with structural elements of the Thioredoxin fold
in gray and additional elements in white. In each case, the location of the CXXC and cisPro loop and N- and C- termini are
indicated. Arrows represent b-strands, and a-helices are displayed as cylinders. This figure was made using TopDraw (23).
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(Leu40, Ile42, Leu147) residues and was recently shown to be
critical for binding to EcDsbB during the catalytic cycle (108).
Even though this groove is vital for the re-oxidation of
EcDsbA, as discussed below, other structurally characterized
DsbA proteins have differing features in this region.
B. The inserted helical domain
The EcDsbA crystal structure revealed that this 21 kDa
monomeric protein not only possesses a Thioredoxin fold
comprising about 90 residues, it also contains a large a-helical
domain inserted into the middle of the Thioredoxin fold (Fig.
7C). One interesting feature observed in the a-helical domain
of EcDsbA is a hydrophobic patch, located just above the
active site CXXCmotif (151). It is thought that this regionmay
play a role in substrate recognition: recent work showed that
residues from this inserted helical domain are involved in
binding substrates (see Section IV below for further detail)
(167). Additional evidence for such a role has come from the
manyDsbA structures now available in the Protein Data Bank
(PDB). These structures illustrate that DsbA proteins from
different species exhibit unique surface characteristics in re-
gards to this a-helical domain. These variations suggest that
this region may contribute to substrate specificity. Additional
evidence for a function of the a-helical insertion domain is
revealed by the study of multiple DsbA paralogues from a
single organism. The structural rearrangements and surface
variation of this region within DsbAs from a single species
illustrates that these different DsbAs may have unique or
perhaps limited overlapping substrate specificity.
C. Invariant and highly conserved residues
Although structurally characterized DsbA proteins share a
similar architecture, there is very little in common when their
primary amino acid sequences are compared. A recent analysis
of 421 bacterial genomes identified 330 DsbA homologues of
widely varying sequence identities (92). Two residues that are
absolutely conserved in all sequences are the catalytic cysteine
residues of the CXXC motif. These residues are positioned at
the amino-end of the a1-helix and form the catalytic redox ac-
tive site of DsbA (Fig. 7C). Studies of the dipeptide residues
FIG. 8. The binding interface of the EcDsbA and EcDsbB complex. (A) Diagram of EcDsbA in an orientation similar to
that used in Figure 6, showing the surface features of the protein. Shaded in black is the region of EcDsbA that interacts with
P2 of EcDsbB, and shaded in white is the region that interacts with P20. The hydrophobic groove is indicated by an arrow, and
the active site is represented with a white S. (B) PDBsum (138) analysis of the EcDsbB–EcDsbA complex (from the structure
with PDB code 2ZUP) (107) illustrating the residues that form interactions at the protein–protein interface. For nonbonded
contacts, the width of the striped line is proportional to the number of contacts. Only one hydrogen bond is present, shown as a
solid gray line, between backbone atoms of Arg148 of EcDsbA and Phe106 of EcDsbB. (C) Closeup of the P2 interaction site,
with the EcDsbB P2 represented in white with the N-terminal end labeled.
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connecting the cysteine residues have revealed that, although
the EcDsbA sequence (CPHC) is present in a number of other
homologues, the identity of these residues can vary amongst
the functional DsbAs (78, 160, 175). These studies highlight not
only the important role of the CXXC motif in redox proteins,
but also the influence of the dipeptide sequence on the redox
potential and in turn protein function.
An analysis of the individual residues of the dipeptide re-
veals that the N-terminal residue is a proline residue in 11 of
13 (85%) characterized DsbA structures. The two variants are
the NmDsbA3 (PDB ID 3DVX) (137) that has a valine residue,
and theWolbachia pipientis DsbA1 (PDB ID 3F4R) (WpDsbA1)
(135) that contains a tyrosine at this position. It is interesting to
note that both of these organisms possess multiple putative
dsbA sequences. N. meningitidis contains three dsbA genes;
both of the other two DsbA sequences (NmDsbA1 and
NmDsbA2) contain the EcDsbA dipeptide sequence (CPHC).
Analyzing the role of each N. meningitidis DsbA via gene de-
letion has shown that the presence of at least one protein
containing the PH dipeptide is sufficient for full virulence
(203). In regards to W. pipientis, two putative dsbA sequences
have been identified (134). As indicated above, WpDsbA1 has
a tyrosine as the first residue in the dipeptide. The other DsbA,
WpDsbA2, (W. pipientis wMel, GeneID: 2737836), has a GH
dipeptide in the CXXC motif, which curiously, is the dipep-
tide sequence typically found in the active sites of eukaryotic
PDI (150). W. pipientis does not encode a DsbA with a PH
dipeptide. It also does not encode sequences for proteins of
the isomerase pathway and therefore the W. pipientis DsbA
proteins likely fulfill differing roles compared to EcDsbA.
The only other invariant residue on theDsbA scaffold of the
330 DsbA sequences is the cisPro residue located in the loop
joining the a2-helix and the b3-strand of the Thioredoxin fold
(a6-helix and b4-strand in EcDsbA). This residue is located at
position 151 in the EcDsbA sequence and is thus relatively
distant from the active-site cysteine residues (Cys30 and
Cys33) in the primary sequence. However the cisPro is posi-
tioned very close to the active site cysteines in the three-
dimensional fold and forms part of the active site. Mutational
studies have revealed that the cisPro loop plays an important
role in redox function. Functional and biophysical studies
have revealed that the cisPro of EcDsbA plays a key role in the
stability and function of this protein (30, 161). Mutation of this
proline to alanine results in a loop with a different confor-
mation to the wild-type protein, and both redox states of the
P151A mutant are less stable than the wild type. Measure-
ments revealed that the P151A substitution results in a re-
duction of the oxidizing power of EcDsbA (30, 161). Similar
changes in activity have been reported for cisPro mutants of
Vibrio cholerae DsbA (VcDsbA also known as TcpG) (21).
Further in vivo analysis of EcDsbA cisPro mutants suggests
that this residue plays an essential role in substrate release,
because site-directed mutants of this residue result in the ac-
cumulation of mixed disulfide intermediates with substrates
(121, 122) (see also Section VA). This observation is supported
by crystal structures of both thioredoxin and EcDsbA bound
to substrates, where the cisPro has been shown to be critical
for the orientation of loop residues that can interact with
substrate molecules (108, 147). Finally, studies on human
thioredoxin show that the cisPro residue prevents metal
binding to the reactive thiolate-based active site, further
supporting a key role in substrate recognition (199).
In addition to the functionally important residues already
discussed, there are four highly conserved hydrophobic resi-
dues that play critical structural roles. In the structurally
characterized DsbA proteins Val22, Phe26, Phe93, and Val155
(numbering is from the EcDsbA sequence) align in almost all
structures. The two valine residues are located in the central b-
strands of the Thioredoxin fold maintaining the hydrophobic
core of the fold and aiding in the positioning of the cisPro loop
near the active site. These valine residues can be replaced by
leucine, isoleucine, or (in the case of WpDsbA1) methionine.
The side chains of the two highly conserved phenylalanine
residues are part of a hydrophobic cluster located between the
Thioredoxin fold and the inserted a-helical domain. This hy-
drophobic cluster positions the a3-helix above the active-site
disulfide, and this may be important for substrate recognition.
Phe26, located on the b2-strand, is not strictly conserved in all
sequences of the DsbA structures; functionally it can be re-
placed by a phenylalanine from b3-strand as seen in the
structures of SaDsbA, BsDsbA, and WpDsbA1 [PDB codes
3BCI, 3GH9, and 3F4R, respectively (37, 90, 135)]. Phe93 is not
conserved in the two structurally characterized DsbA para-
logues, EcDsbL and SeDsbL. These both contain an extended
loop at the N-terminal end of the a3-helix, which replaces the
phenylalanine with a tyrosine.
D. Structural features of the interaction with DsbB
A recently updated model of the EcDsbA–EcDsbB crystal
structure has enabled the sites of interaction between these
important proteins to be better defined (107). The EcDsbA
structure has a hydrophobic groove running along the surface
of the protein near the active-site cysteine residues (151) (Fig.
8A). This groove is involved in binding to the N-terminal
portion of the second EcDsbB periplasmic domain (P2) in all
three EcDsbA–EcDsbB crystal structures determined to date
(107, 108, 149). An interesting observation from all of the
structures is that, in addition to the four transmembrane a-
helices and two periplasmic loops (P1 and P2) previously
predicted for EcDsbB, an additional short a-helix located at
the periplasmic face of the membrane was identified in the C-
terminal P2 loop (Fig. 5). This short a-helix, encompassing
residues 116 to 120 tethers the second periplasmic loop of
EcDsbB to the membrane generating two shorter loops (P2
and P20), P2 contains Cys104 and P20 contains Cys130. The
short a-helix serves as an anchor to the membrane and
likely provides a pivot point enabling the two cysteines of
this periplasmic domain to effectively and rapidly oxidize
EcDsbA (107).
Analysis using the web-based program PDBsum (138) of
the most recent crystal structure of the EcDsbB–EcDsbA
mixed disulfide complex reveals that residues other than the
cysteines of both molecules are involved in complex forma-
tion. A total of 26 residues, 13 from EcDsbA and 13 from
EcDsbB, have so far been identified to form the interface (Fig.
8B). In addition to the disulfide bond between EcDsbA Cys30
and EcDsbB Cys104, a hydrogen bond is formed between the
backbone oxygen of EcDsbA Arg148 and the backbone ni-
trogen of EcDsbB Phe106. Other interactions are hydrophobic.
The only invariant DsbA residues involved in the interaction
between EcDsbA and EcDsbB are Cys30 and cisPro151; there
is very little conservation in the remaining 11 residues iden-
tified at the protein–protein interface.
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Although not definitive given the limited resolution of the
available EcDsbA–EcDsbB crystal structures, it is now be-
coming evident that the P20 region of EcDsbB that contains
Cys130 may also interact weakly with EcDsbA. This interac-
tion may be important for keeping the Cys130 EcDsbB loop
separated from the Cys104 loop, allowing the latter to oxidize
EcDsbA rapidly (107). The most recently described EcDsbA–
EcDsbB structure reveals that Gly128 of P20 interacts with
Phe63 of EcDsbA (Fig. 8B). Phe63 is located on the loop that
connects the Thioredoxin fold to the a-helical domain of
EcDsbA (between the b3-strand and a2-helix) (Fig. 7C). This
finding is supported by results from a recent saturation
transfer TROSY–HSQC NMR experiments on a sample of 2H,
13C, 15N-labeled EcDsbB and unlabeled EcDsbA (234), where
it was shown that Gly128 of P20 interacts with EcDsbA. Taken
together, there is now good evidence that there are two DsbB
binding sites on EcDsbA, one which binds P2 (including
Cys104) and the other which binds P20 (containing Cys130).
However, many structurally characterized DsbA molecules
possess surface features different to those of EcDsbA in these
two binding sites, suggesting the possibility of species-specific
recognition of DsbB.
E. Structural implications for function
Of the numerous enzymes now recognized to catalyze re-
dox reactions, DsbA is one of the strongest thiol oxidants, with
EcDsbA having a redox potential of 122mV (100). This en-
zyme catalyzes the formation of disulfide bonds in substrate
proteins rapidly both in vivo and in vitro. In contrast, thior-
edoxin has a much lower redox potential of approxima-
tely 270mV; it functions as a disulfide reductase in the
cytoplasm (5).
As discussed previously, the catalytic cysteines of the
EcDsbA CXXC motif, Cys30 and Cys33, are located at the N-
terminus of the a1-helix of the Thioredoxin fold (Fig. 7). The
more N-terminal of the two cysteines, Cys30, is surface ex-
posed. The unique structural and biophysical properties of the
Cys30 residue impart strong thiol oxidant properties to
EcDsbA. As indicated above, Cys30 has an abnormally low
pKa value of approximately 3.5 (72, 163, 223, 229) so that it
adopts the thiolate anion state at physiological pH. Further-
more, the reduced form of the protein is stabilized with re-
spect to the oxidized form (229), in contrast to the effect of
most protein disulfides.
Structural studies have revealed details of how the Cys30
thiolate anion is stabilized, giving rise to the observed sta-
bility of reduced EcDsbA in comparison to the disulfide-
bonded form. In the crystal structure of oxidized EcDsbA,
Cys30 is located at the N-terminus of the a1-helix, so that the
partial positive charge from the helix dipole could aid in
stabilizing the thiolate form of the cysteine (151) (Figs. 6 and
7C). Positioning of the CXXC motif on the helix dipole is a
conserved feature of redox active Thioredoxin fold proteins,
which all exhibit lowered pKa values for the N-terminal
cysteine residue of *7 (compared with typical value for
cysteine of*9) (46, 72, 85). Mutagenesis studies indicate that
His32 is important for the redox stability profile of EcDsbA,
suggesting that favorable interactions with the His32 side-
chain and Cys30 thiolate anion are likely to be present (72).
Indeed, in one of the two monomers observed in the crystal
structure of reduced EcDsbA, His32 adopts a conformation
that is within hydrogen bonding distance of the Cys30 sulfur
(79). Quantum mechanical studies of active site models
suggest that differential stabilization of the two cysteines in
the CXXC motif may give rise to the differing enzymatic
properties of Thioredoxin fold proteins (28). Thus, oxidants
like DsbA are characterized as having an active site with two
strongly stabilized cysteine thiolates; reductants like thior-
edoxin as having two poorly stabilized thiolates; and isom-
erases like DsbC as having only the C-terminal buried
cysteine thiolate stabilized (28).
A recent study has examined the role of the residue that
precedes the cisPro located near the active site (179). Mu-
tational analysis identified that this residue is at least as
important in determining the redox properties of Thior-
edoxin fold proteins as the dipeptide of the CXXC motif. Of
the structurally characterized DsbA proteins, the residue
preceding the cisPro is generally either a valine or threonine
(Table 1). When present as a valine, as in EcDsbA, a hy-
drophobic interaction is formed with Cys30 of the active
site (80, 151). However, in DsbA enzymes where this resi-
due is a threonine, a hydrogen bond can form between the
Thr hydroxyl group and the reactive cysteine sidechain.
Similar to the interactions described above, the hydrogen
bond formed between these two residues would favor the
thiolate or reduced form of the cysteine. This thereby de-
stabilizes the oxidized form of DsbA and has a significant
effect on the reactivity of the DsbA disulfide bond. The
interaction is therefore predicted to favor oxidase activity of
DsbA (179) and is generally supported by the structurally
characterized DsbA proteins: those with a Cys–Pro–His–
Cys sequence, similar to EcDsbA, but with a Thr residue
preceding the cisPro typically have an increased redox
potential compared with EcDsbA (Table 1). One exception
is Pseudomonas aeruginosa DsbA (PaDsbA): it has valine
preceding the cisPro and a highly oxidizing redox potential.
In this case, Trp34 of PaDsbA (located in the loop preceding
the CXXC motif ) may help to stabilize the thiolate anion
via hydrophobic interactions, giving rise to the increased
redox potential.
IV. Variations to the Archetypal DsbA Fold
To date, 13 DsbA homologues from 10 organisms have
been both structurally and functionally characterized (Table
1). Furthermore, the structures of four other DsbA-like pro-
teins have been deposited into the PDB—without accompa-
nying functional characterization or publications—by two
structural genomics consortia, the Midwest Center for Struc-
tural Genomics (MCSG) and the New York SGX Research
Center for Structural Genomics (NYSGXRC) (Table 1).
DsbAhomologues fromdifferent organisms share very low
sequence identity overall (generally 15%–40%) (92). None-
theless, the main structural elements present in EcDsbA (151;
Fig. 7) are generally conserved across DsbA structures from
different bacterial genera. Hence, the DsbA-like protein
structures so far elucidated contain a Thioredoxin foldwith an
inserted helical domain. However, differences in primary se-
quence give rise to unique structural features that distinguish
DsbAs originating from different bacteria. In this section, we
summarize the structural characteristics of the DsbA-like
proteins deposited in the PDB and compare these to the ar-
chetypal EcDsbA structure.
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A. DsbA structures from gamma-proteobacteria
So far, most of the DsbA proteins that have been structur-
ally characterized belong to the phylum Proteobacteria, spe-
cifically the gamma-Proteobacteria. These DsbAs share the
highest sequence identity with EcDsbA and therefore are not
surprisingly also the closest structural homologues. One
protein that attracted early attention is VcDsbA because of the
key role this enzyme plays in the assembly of the co-regulated
pilus (Tcp) necessary for V. cholerae to colonize its host and
establish an infection (169) (see Section VI below). VcDsbA
shares*40% sequence identity with EcDsbA; it has a similar
overall architecture (compare Figs. 9A and 9B; root mean
squared deviation (rmsd) of 1.3 A˚ for 167 aligned Ca atoms)
and an identical CXXC motif (Cys30–Pro31–His32–Cys33).
However, the structure of the V. cholerae protein diverges
from that of EcDsbA in at least two respects. First, the active
site helix a1, is less bent than that of EcDsbA (Fig. 9C; angle
between the two helices is 408 comparedwith 508 for EcDsbA)
(99). The kink is caused by a 3-residue ‘‘loop-out’’ in EcDsbA,
whereas in VcDsbA it is caused by a proline. Although a
kinked active-site helix appears not to be necessary for DsbA
function, this feature is relatively conserved among Thior-
edoxin fold proteins (88). Second, the length of the C-terminal
helix a7 is much shorter in VcDsbA compared with EcDsbA;
this helix forms one of the edges of the hydrophobic groove
located immediately adjacent to the CXXC active site (151). As
indicated in Section III, the groove is part of the binding site
for the redox partner protein EcDsbB (108). Helix a7 is six
residues shorter in VcDsbA compared with EcDsbA (Figs. 9A
and 9B). This truncation results in a considerably shortened
hydrophobic groove (99).
FIG. 9. Topologies of DsbA proteins. Topology of (A) EcDsbA; (B) VcDsbA(TcpG)=PaDsbA; (D) UPEC EcDsbL, (E)
XfDsbA; (F) WpDsbA1; (G) BsBdbD. The architecture of the Thioredoxin fold is shown in dark gray, and inserted regions are
shown in white. Asterisks show regions of major divergence compared with EcDsbA. Triangles indicate the cisPro loop. (C)
Comparison of the kinked a1 helix of EcDsbA (left, white) and VcDsbA (right, black) showing the more marked kink in EcDsbA
induced by a 3-residue loop-out of the helix, whereas the helical kink of VcDsbA is caused by a proline. For orientation
purposes, the EcDsbA active site cysteine sulfurs at the N-terminus of the a1 helix are shown as spheres (left panel).
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The structure of a secondDsbA from the genusVibrio,Vibrio
fischeri DsbA (VfDsbA), is now available. Although to date no
biochemical or functional characterization of this protein has
been reported, VfDsbA contains all the structural hallmarks of
DsbA-like proteins, including the Thioredoxin and helical do-
mains and the canonical CXXC active motif (Cys31–Gly32–
His33–Cys34). However, VfDsbA shares just 23% sequence
identitywithEcDsbAand their structures superimposewith an
rmsd of 2.1 A˚ for 158 Ca atoms. In addition to the structural
differences identified for VcDsbA, VfDsbA also exhibits dif-
ferences in the helical domain, including the position of the a5-
helix and the loops connecting the inserted helices, which are
shifted relative to both EcDsbA and VcDsbA.
Another gamma-Proteobacterium DsbA structure recently
investigated is PaDsbA (192). This protein plays a pivotal role
in the pathogenicity of the opportunistic human pathogen P.
aeruginosa by folding a diverse array of virulence factors re-
quired by this organism to infect the host (192) (see Section
VI). A structural superposition of PaDsbA and EcDsbA gives
an rmsd of 2.2 A˚ (for 164 Ca atoms). Like the DsbAs from the
genus Vibrio, PaDsbA also has a less pronounced kink in helix
a1, caused by a proline in the helix sequence, and it also has a
truncated a7-helix groove (Fig. 9B) resulting in a shortened
surface groove. Moreover, the relatively low homology be-
tween PaDsbA and EcDsbA (they share 27% sequence iden-
tity) gives rise to different electrostatic surfaces. Thus,
PaDsbA has a smaller hydrophobic patch adjacent to the ac-
tive site compared with EcDsbA, and overall its surface is
more basic (192).
B. DsbA structures from bacteria with multiple DsbAs
Many bacteria encode oxidative protein-folding machin-
ery, but the type and number of DsbA homologues in these
pathways varies enormously from one bacterium to another
(49, 92). This variability is particularly apparent amongGram-
negative pathogens, some of which contain an extended ar-
senal of thiol-disulfide oxido-reductases (73, 137). Recently,
several research groups have carried out comprehensive
structural and functional characterizations of DsbA homo-
logues from pathogens encoding a wide repertoire of DsbA
proteins. For example, N. meningitidis, the causative agent of
meningitis and meningococcal septicemia, encodes three
DsbA-like proteins; two lipoproteins anchored to the inner
membrane (NmDsbA1 and NmDsbA2 that share 78% se-
quence identity with each other), and a soluble periplasmic
protein NmDsbA3 (194, 203). As mentioned in Section IIIC,
NmDsbA1 and NmDsbA2 have a CPHC redox active site
while NmDsbA3 has a CVHC motif. All three Neisserial en-
zymes have a Thr-cisPro sequence in the cisPro loop (EcDsbA
contains a Val-cisPro), which plays an important role in de-
termining the strong oxidizing power of these three enzymes
(137, 179, 211).
Two crystal structures are available for the soluble portions
of both NmDsbA1 (3A3T (211) and 3DVW (137)) and
NmDsbA3 (2ZNM (212) and 3DVX (137)). The twoNmDsbA1
structures are similar to each other (rmsd of 1.0 A˚ for 189 Ca
atoms). However, the two NmDsbA3 structures exhibit a
relatively low structural similarity (rmsd of 2.3 A˚ over 183 Ca
atoms). This is principally due to differences between the
active site conformations in the two NmDsbA3 crystal struc-
tures. In the 3DVX NmDsbA3 structure, the CVHC active site
adopts the right-hand hook conformation observed in other
Thioredoxin fold proteins (104) with the two sulfur atoms of
the cysteines separated by 3.5 A˚ in the reduced form (137). In
the 2ZNM NmDsbA3 structure, the redox catalytic site is not
located at the N–terminus of a helix but instead adopts an
open looped conformation with the sulfur atoms of the two
cysteines separated by 14 A˚ (212). This CXXC conformation is
unprecedented among Thioredoxin fold proteins and it re-
mains to be determined if it is biologically relevant to
NmDsbA3 or is an artifact of crystallization or X-ray expo-
sure. For the purposes of our structural comparison with
EcDsbA, we have used the 3DVX NmDsbA3 coordinates.
NmDsbA1 and NmDsbA3 share 23% and 22% sequence
identity with EcDsbA, respectively, and their atomic structures
can be superimposed with the E. coli homologue with an rmsd
of 2.2 A˚ (157 Ca atoms aligned) and 2.2 A˚ (157 Ca atoms
aligned), respectively. The structures of the two Neisserial en-
zymes are similar, superimposing with an rmsd of 1.1 A˚ over
186 Ca atoms (137). Several structural differences exist in re-
gions surrounding the active site; for example, the a1-helix is
distinctly kinked in EcDsbA but is less so in the Neisserial
protein structures. Furthermore, a shorter loop connects b5 and
a7, and a7 is shorter by 1.5 turns than the equivalent helix in
EcDsbA, resulting in a more shallow groove in NmDsbA1 and
NmDsbA3. In these respects the NmDsbA1 and NmDsbA3
structures are similar to those ofVcDsbAandPaDsbA (Fig. 9B).
Structural differences with EcDsbA also occur in the helical
domains of NmDsbA1 and NmDsbA3 with variations in the
length and position of the loops connecting the helices and the
orientation of helix a5 (137, 211, 212).
Finally, NmDsbA1 and NmDsbA3 have distinct surface
properties; NmDsbA3 retains most of the surface characteris-
tics of EcDsbA including the hydrophobic patch (thought to be
important for substrate binding) and the hydrophobic groove
(which interacts with DsbB). In NmDsbA1, the hydrophobic
patch and a groove are present, albeit the latter is principally
composed of acidic rather than hydrophobic residues (137).
Multiple DsbA proteins are also found in uropathogenic
E. coli (UPEC). In addition to the oxidase and isomerase
pathways found in E. coli K-12, this organism also has the
DsbL=DsbI proteins which form a second functional redox
pair (73, 205). UPEC EcDsbL and EcDsbA are 24% identical in
sequence (with different catalytic sites, CPFC versus CPHC,
respectively) and their structures are divergent. Superposition
of the atomic models of UPEC EcDsbL and EcDsbA (rmsd of
2.1 A˚ over 162 Ca atoms) reveals considerable variability in
both the Thioredoxin and helical domains. Two major dif-
ferences in the Thioredoxin fold of EcDsbL include bending of
the connecting helix a6 towards the b4b5a7 motif and trunca-
tion of that motif by 6 residues (73; Fig. 9D). The effect of these
two modifications is that UPEC EcDsbL has a considerably
shortened groove. Furthermore, this groove is lined with
positively charged rather than hydrophobic residues. Struc-
tural variations also map to the helical domain of UPEC
EcDsbL where helices a2, a3, a4, and a5 are shifted by about
one helical turn relative to EcDsbA (73), and longer loops
connect a2 and a3, and a3 and a4 (Fig. 9D).
Another Gram-negative pathogen with an extended col-
lection of DsbA proteins is the causative agent of acute human
gastroenteritis Salmonella enterica serovar Typhimurium (93).
Like E. coli K-12 this organism contains an oxidase and
isomerase system; it also has a DsbL=DsbI redox pair similar
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to that present in UPEC; and it has a virulence plasmid-en-
coded DsbA-like protein, called SeSrgA. The three S. typhi-
murium DsbA paralogues, SeDsbA, SeDsbL, and SeSrgA,
have been structurally and functionally characterized recently
(93). SeDsbA shares 85% sequence identity with EcDsbA and
as expected these two share very similar structures (rmsd 0.7
A˚ over 178 Ca atoms). SeSrgA has 35% sequence identity with
EcDsbA and pairwise comparison with EcDsbA gives an
rmsd of 1.4 A˚ (172 Ca atoms) for the two structures. Thus,
SeSrgA is one of the closest structural homologues to EcDsbA
(93), yet they have very different active site motifs (CPPC and
CPHC, respectively) and different residues preceding the
cisPro residue (Thr-cisPro and Val-cisPro, respectively).
Moreover, the groove is very different in these two proteins. It
is truncated in SeSrgA mainly because of an altered orienta-
tion of the loop between a6 and b4, immediately preceding
Thr147-cisPro148, which forms one edge of the groove in
EcDsbA (151). This loop points away from the hydrophobic
groove in EcDsbA, resulting in a relatively extended cavity,
whereas in SeSrgA the same section of the protein is posi-
tioned more towards the b1-strand at the N-terminus of the
Thioredoxin fold. This orientation that shortens the groove is
possibly secured by a salt bridge between the side chains of
Arg145 and Glu7 (3.7 A˚) (93). SeDsbL is closely related to
UPEC EcDsbL both in sequence (93% sequence identity) and
structure (rmsd of 0.4 A˚ over 195 Ca atoms; Fig. 9D) and
consequently shows all the characteristic features distin-
guishing UPEC EcDsbL from EcDsbA (93). SeDsbL shares
26% identity with EcDsbA and their structures can be su-
perimposed with rmsd of 2.1 A˚ for 161 Ca atoms.
The Gram-negative plant pathogen Xylella fastidiosa, which
causes economically important diseases in many crops in-
cluding grape, citrus, almond, alfalfa, peach, and coffee,
contains two adjacent genes coding for two DsbA homo-
logues (182). XfDsbA and XfDsbA2 are 41% identical and
despite not sharing the same catalytic site sequence (CPHC
and CPAC, respectively), both have similar redox potentials
(–94 and 100mV, respectively (182)) and are stronger oxi-
dants than EcDsbA (–122mV) (100). To date, only the struc-
ture of XfDsbA has been solved (182). Superposition of
EcDsbA and its counterpart XfDsbA (19% sequence identity)
results in an rmsd of 2.1 A˚ (167 Ca atoms). Like almost all the
DsbA proteins structurally characterized since EcDsbA, the a1
helix of XfDsbA is less kinked than that of EcDsbA and it has a
truncated groove (182). Other structural differences between
XfDsbA and EcDsbA include insertions in loops connecting b1
and b2, and a3 and a4, and a deletion in the loop between b3
and a2 (Fig. 9E); the equivalent loop in EcDsbA is involved in
the interaction with EcDsbB (108).
The a-Proteobacterium W. pipientis is one of the most suc-
cessful endosymbionts in the biosphere, infecting many spe-
cies of arthropods and nematodes (94, 116). W. pipientis
encodes two DsbA-like proteins WpDsbA1 and WpDsbA2
(also called aDsbA1 and aDsbA2) and a homologue of
EcDsbB, but lacks an isomerase pathway (135). The recent
structural and biochemical characterization of WpDsbA1
showed that this protein diverges considerably from EcDsbA
in sequence (10% identity), biochemical properties and
structure (rmsd 2.9 A˚ for 137 Ca atoms) (135).WpDsbA1 has a
DsbA-like architecture, yet it also contains distinct structural
characteristics, including a different topology (strand b1 is
hydrogen bonded to the opposite edge of the central b-sheet
(Fig. 9F); it lacks the groove altogether due to a deletion in the
b4b5a7 motif. Additionally, WpDsbA1 does not have the hy-
drophobic features of EcDsbA; instead its surface is mostly
basic. Another peculiarity of this protein is the presence of a
second disulfide bond that links helices a2 and a5 of the helical
domain (135; Fig. 10A). The two cysteines forming the second
disulfide are highly conserved in DsbA-like proteins from a-
Proteobacteria, and the disulfide adopts an unusual rotamer
conformation suggesting a functional role, though this remains
to be confirmed.However, the structural discrepancies are also
reflected in unique biochemical properties of WpDsbA1. For
example, this protein is the most reducing DsbA-like protein
so far characterized (redox potential 163mV). Moreover,
FIG. 10. Unusual features of DsbA structures. (A) The
second disulfide bond of WpDsbA1 is shown. This disulfide
links helices a2 and a5 and is located on the surface of the
protein opposite to that revealing the catalytic active site
(PDB code 3F4R) (135); (B) The calcium binding site of
BsDsbA (BdbD) is shown, located between the Thioredoxin
and inserted helical domains. The Ca2þ is coordinated by
Gln49 (Q49), Glu115 (E115), and Asp180 (D180) (PDB code
3GH9) (37).
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WpDsbA1 does not complement the E. coli K-12 dsbA- strain
and it is not reoxidized by EcDsbB (135).
C. DsbA structures from Gram-positive bacteria
Gram-positive genomes exhibit great diversity in the
number and type of Dsb proteins they encode. For example,
Bacillus subtilis has one homologue of DsbA and two homo-
logues of DsbB; pathogens like S. aureus and Listeria mono-
cytogenes encode just a homologue of DsbA and lack other
Dsb-like proteins; other Gram-positive bacteria like Bacillus
halodurans and Geobacillus kaustophilus encode just a DsbB
orthologue (132). As described in Section II above, some
Gram-positive bacteria including Streptococcus pyogenes do
not encode Dsb-like proteins.
To date, the structures of two Gram-positive DsbA proteins
have been investigated; those of S. aureusDsbA, SaDsbA (90),
and B. subtilis BsDsbA (37) (known as BdbD). On the basis of
sequence and structures, these two proteins are only remotely
related to EcDsbA (16% and 15% sequence identity, respec-
tively; rmsd 2.6 A˚ and 2.2 A˚ for 122 and 152 aligned Ca atoms,
respectively) and contain significant structural variations
from EcDsbA (37, 90). As with most other DsbA structures,
helix a1 in these two Gram-positive DsbAs is less kinked than
in EcDsbA. Second, both proteins include longer and nega-
tively charged loops between helices a3 and a4 in the helical
domain, which map close to the CXXC active site. Their active
sites differ from the catalytic motif in EcDsbA (CPYC and
CPSC, respectively, compared with CPHC of EcDsbA). Third,
BsDsbA and SaDsbA have truncated grooves compared with
EcDsbA due to a deletion in the bba domain. Moreover, in
BsDsbA the b1 strand adopts the same topology asWpDsbA1,
interacting with b3 rather than b5 (Fig. 9G). Finally, BsDsbA
has an intrinsic Ca2þ binding site, which is absent in other
DsbA proteins characterized to date (Fig. 10B). Interestingly,
cation binding affects the redox properties of the protein, in
that it selectively stabilizes the reduced form of the protein
and thereby increases its oxidizing power, despite the fact that
the Ca2þ ion is located*14 A˚ from the redox catalytic centre
of BsDsbA (37).
D. Structures of other DsbA homologues
Two structural genomics consortia have deposited into the
PDB three other proteins identified as DsbA homologues:
Nitrosomonas europaea DsbA (NeDsbA); Streptomyces coelicolor
DsbA (ScDsbA); and Bordetella parapertussis DsbA (BpDsbA).
Superposition of EcDsbA and its counterparts NeDsbA (11%
sequence identity), ScDsbA (17% sequence identity), and
BpDsbA (23% sequence identity) resulted in rmsds of 2.9 A˚
(137 Ca atoms), 2.5 A˚ (140 Ca atoms) and 2.0 A˚ (145 Ca atoms),
respectively.
The architecture of NeDsbA and ScDsbA structures re-
sembles that of EcDsbA, incorporating a Thioredoxin fold and
an inserted helical domain. For NeDsbA, the a1 helix is less
kinked than that of EcDsbA; it has a proline in the sequence
rather than the 3-residue loop-out of EcDsbA. By contrast, the
ScDsbA structure lacks both the proline and the kink in the a1
helix. Both NeDsbA and ScDsbA have a deletion in the bba
motif, resulting in a truncated groove, but overall the Thior-
edoxin domains compare reasonably well with that of EcDs-
bA. However, the helical insertion domain in both NeDsbA
and ScDsbA differs considerably from that of EcDsbA, com-
prising seven rather than the usual four a-helices (Fig. 11A),
C
N
N
C
b3
a6a5
a1a2a3a4
a7
b5
b4b2
b1a aa
b3
a6
a5 a1a2a3a4
a7
b5
b4b2
b1
A
B
* **
*
*
*
FIG. 11. Structural genomics DsbA structures. Topology diagrams of (A) NeDsbA and ScDsbA and (B) BpDsbA. The
architecture of the Thioredoxin fold is shown in dark gray, and insertions are shown in white. Asterisks show regions of major
divergence compared with EcDsbA.
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and thus more closely resemble the k-class of glutathione S-
transferases (k-GSH transferases). Indeed, a Dali search (97)
indicated that the closest structural homologues to NeDsbA
and ScDsbA are k-GSH transferases, human kappa class
glutathione 2 transferase (15% sequence identity, PDB code
1YZX) and mitochondrial kappa class glutathione transferase
(13% sequence identity, PDB code 1R4W), respectively.
Nevertheless, NeDsbA and ScDsbA retain the catalytic CXXC
motif of DsbA proteins whereas the two k-GSH transferases
so far structurally characterized have instead a SXXS active
site (136, 141). Neither the NeDsbA nor the ScDsbA structures
have been reported in the literature. Given their structural
similarity to both DsbAs and k-GSH transferases, functional
studies would be required to confirm their biochemical
function.
The structure of BpDsbA has an unusual conformation of a7
at the C-terminus of the Thioredoxin fold, which is extended
away from the core fold (Fig. 11B). This feature has not been
observed in other Thioredoxin fold containing proteins,
which all have a relatively compact bba domain. The con-
formation observed in this crystal structure may be an artifact
related to the packing of three molecules in the crystal because
the extended a7-helix of one monomer packs against the
Thioredoxin fold of another monomer in the asymmetric unit.
V. Ligand Binding by DsbA
In Gram-negative Proteobacteria like E. coli the oxidation of
substrate proteins is thought to occur in a stepwise manner
(106). In the first step, EcDsbA interacts with an unfolded
substrate protein that has just been translocated into the
periplasm; this involves formation of a mixed disulfide bond
between the reactive cysteine of EcDsbA and a cysteine of the
substrate. In the second step, a deprotonated cysteine in the
substrate helps to resolve the mixed disulfide, thus forming
oxidized substrate and leaving EcDsbA reduced. Finally,
EcDsbA is rapidly re-oxidized by its partner protein EcDsbB.
The transition between EcDsbA-substrate complex and fully
oxidized substrate is relatively rapid so that it has been dif-
ficult to capture and characterize the EcDsbA-substrate
complex (122). To investigate this step, different approaches
have been used.
A. Identification of DsbA substrates
One strategy to trap EcDsbA–substrate complexes has been
to mutate residues in the cisPro loop (Val150-cisPro151 in
EcDsbA). As indicated above, the cisPro loop is highly con-
served in proteins with a Thioredoxin fold, so this approach
could provide a general method to detect substrates in other
DsbA proteins. Three such EcDsbA mutations—P151T, P151S,
and V150G—yielded important outcomes (122). The first mu-
tant, P151T, was shown to slow the second step of oxidative
folding that releases the oxidized substrate protein after in-
teraction with EcDsbA. Hence, the P151T mutation resulted in
the accumulation of EcDsbA complexedwith substrates (122).
By contrast, the P151S mutant exhibited accumulation of an-
other intermediate, the complex between EcDsbA and
EcDsbB (71, 118, 130). This mutant therefore showed a defect
in the mechanism to release oxidized EcDsbA from EcDsbB.
The third mutation, V150G, also demonstrated a defect in the
step involving EcDsbA–EcDsbB complex formation, though
there was much less accumulation of the complex and half of
the EcDsbA in the periplasm remained reduced (122). Sixteen
other mutations of the cisPro residue were also investigated
(121). However, aside from P151T, no other mutation was able
to accumulate EcDsbA–substrate complexes. Kadokura and
co-workers carried out pulse-chase experiments to identify
the substrates complexed to the EcDsbA P151T mutant (122).
Cellular proteins were labeled, and complexes with EcDsbA
P151T were separated by diagonal electrophoresis and the
identity of bound partner proteins confirmed by mass spec-
trometry (122). Putative partners were then verified as
EcDsbA substrates by investigation of their redox state in
wild-type and DdsbA strains of E. coli.
Kadokura et al. investigated the oxidative folding of the
EcDsbA substrate alkaline phosphatase (PhoA) (119), a
homodimeric periplasmic protein harboring two disulfide
bonds in each subunit. The results of this study suggested that
disulfide bond formation can occur co-translationally (119).
However, it has also been suggested that post-translational
export exceeds co-translational export and this may impact on
the oxidative folding rate and pathway, reviewed in (120).
In addition to trapping DsbA–substrate complexes, other
methods have proven useful for identifying substrates and
their abundance, including: two-dimensional gel analysis
combined with mass spectrometry (96), differential thiol
trapping (140), and differential two-dimensional liquid chro-
matographic tandem mass spectrometry=mass spectrometry
analysis (209). In a recent review, Collet and Messens (33)
describe methods for identifying substrates of thioredoxin
that could also be applied to DsbA enzymes. These include
mutating to alanine themore C-terminal active site cysteine so
that mixed disulfide intermediates are not resolved and
Tandem Affinity Purification (TAP) where a TAP-tag is used
to purify thioredoxin-substrate complexes on affinity col-
umns, followed by identification of the substrate by mass
spectrometry (33).
B. DsbA structures with bound peptides
Several DsbA structures have now been described with
peptides or small molecules bound (37, 93, 135, 167, 182, 192).
The first DsbA–substrate complex to be described was the
complex of EcDsbA with its upstream redox partner EcDsbB.
This complex revealed that the periplasmic loop of EcDsbB
binds in the hydrophobic groove of EcDsbA. Interactions are
formed between the periplasmic loop P2 of EcDsbB and res-
idues Arg148–Gly149–Val150–cisPro151 of the EcDsbA cisPro
loop and between EcDsbB residues Pro100-Phe101-Ala102
and residues Thr168, Met171, and Phe174 of the hydrophobic
groove of EcDsbA (Fig. 8).
Recently, other structurally characterized DsbA complexes
have revealed further information about substrate inter-
actions. The structure of EcDsbA in a complex with a nine-
residue peptide derived from the autotransporter protein
SigA of Shigella flexneri revealed that the peptide binds to the
hydrophobic patch of EcDsbA via the formation of backbone
hydrogen bonds to a loop immediately preceding the cisPro
residue (167) (Figs. 12A and 12B). To stabilize the EcDsbA:
peptide complex for crystallization, the native cysteine in the
nine-residue peptide was replaced by a homoserine (Hse)
residue to give the following sequence: Ac–Pro–Iso–Pro–Phe–
Leu–Hse–Glu–Lys–Asp-NH2. The Hse reacted with Cys30 of
EcDsbA. The EcDsbA active site residues Phe29, Cys30,
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Pro31, and His32, residues Phe63 and Met64 in the loop
connecting the Thioredoxin and helical domains, and residues
Arg148, Gly149, and Val150 of the cisPro loop, comprise 95%
of the binding surface of the SigA peptide with EcDsbA. This
DsbA–peptide complex revealed that the binding site of the
SigA-peptide differs from the EcDsbB binding site, suggesting
that EcDsbB binding may be more specific than that of
downstream EcDsbA substrates.
As indicated above, the plant pathogenX. fastidiosa encodes
two oxidoreductase-like proteins, XfDsbA and XfDsbA2
(182). The crystal structure of XfDsbA incorporates density for
an 8-mer peptide that was modeled into the structure with the
sequence Ala–Ala–Ala–Ala–Ala–Gly–Gly–Ala. This peptide
was not included in the crystallization condition and its exact
sequence is not known. Interaction between XfDsbA and the
peptide occurs in the active site region and the helical domain
mainly through hydrophobic contacts. Hydrophobic interac-
tions were found with XfDsbA residues Cys38, His40, Phe68,
Trp72, Leu150, Gly156, Asp172, and Phe173, and hydrogen
bonds were found with Val155, Gly156, and Thr157 of the
cisPro loop (182) (Figs. 12C and 12D). An additional interac-
tion was identified between the Cys38 side chain and residue
FIG. 12. Ligand binding in DsbA homologues. (A and B) Topology diagram and peptide binding surface, respectively, of
EcDsbA. (C and D) Topology diagram and peptide binding surface, respectively, of XfDsbA. (E, F, and G) Topology
diagrams of PaDsbA, WpDsbA1, and BsDsbA (BdbD), respectively. For all topology diagrams, approximate position of
residues contributing to ligand binding are shown as white dots. For the peptide binding surfaces (B and D), the enzyme is
shown in gray, with the residues contributing to the interacting surface highlighted in black and the peptide shown in white.
Labels indicate: A, active site cysteine; C, peptide C-terminus; N, peptide N-terminus; P, cisProline.
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4 of the peptide. The peptide bound to XfDsbA revealed
similar interactions to those described for the P2 loop of
EcDsbB interacting with EcDsbA, specifically with regard to
anti-parallel interactions with residues of the cisPro loop.
C. DsbA structures with other bound ligands
The closest structural homologue to XfDsbA is PaDsbA
with 37% sequence identity (192). Structural investigation of
PaDsbA revealed the presence of bound small molecules,
specifically four glycerol molecules (Glyc1–Glyc4; glycerol
was included in the crystallization condition). Two of the
glycerols bind to the active site on one surface of the protein,
the other two bind the opposite face of the enzyme (192). Glyc-
1 binds close to the active site in two alternate conformations
and forms hydrogen bonds to side chains of Lys10 and
Arg163 (Fig. 12E). Glyc-2 forms hydrogen bonds with the
backbone of Leu66, and to a symmetry-related residue
Lys124. Glyc-3 binds in an area rich in acidic and basic resi-
dues and forms hydrogen bondswith Asn187. Glyc-4 binds to
Gly119 and Asp121.
The structure of WpDsbA1 from W. pipientis has PEG
molecules bound in two distinct regions (135). The first PEG
binding site is near the active site, in a region that often binds a
water molecule (135). The second PEG binds close to the
second disulfide of this DsbA structure in a region that was
described as resembling a peptide-binding groove (135) (Fig.
12F). The recently determined structure of SeSrgA, the DsbA
from the Gram-negative bacterium S. typhimirium, revealed a
PEG molecule bound in the peptide binding groove near the
CXXC active site (93).
The B. subtilis DsbA homologue BdbD binds Ca2þ (37). The
Ca2þ ion interacts with residues Asp180, Gln49 and Glu115 (Fig.
12G) and is situated *14 A˚ from the active site residues. The
presenceofCa2þ contributes to the catalytic functionofBdbD (37).
D. Common features of binding regions
in DsbA homologues
DsbA interactions with substrates are relatively weak (36),
and even small alterations could lead to divergent substrate
specificities. Thus, different DsbA homologues may interact
with a very specific range of substrates (90, 99, 135, 192, 211).
On the other hand, EcDsbA has been demonstrated to interact
with hundreds of substrates, and to have a very wide sub-
strate specificity (49).
One thing that is evident from the DsbA:substrate com-
plexes solved to date is that substrate interactions all involve
regions directly surrounding the CXXC catalytic motif (90,
135, 182, 192, 212). Thus, the active site motif not only helps
control the redox potential of the enzyme, it also contributes to
interactions with redox partners (175). The cisPro loop near
the active site is also important for substrate binding (12),
including interaction with EcDsbB (108). The hydrogen
bonding pattern between bound peptide and cisPro loop is
similar for both EcDsbA and XfDsbA (Figs. 12A–12D). To-
gether the CXXC and cisPro loop form the central binding site
for substrates, with the nearby groove (if present) and the
surface of the helical domain sometimes providing additional
interaction surfaces. Additionally, peptides bound to EcDsbA
and XfDsbA form interactions with residues in the loop con-
necting b3 of the Thioredoxin domain and a2 of the helical
domain (167, 182) and this region has also been found to
contribute to binding of small molecules to PaDsbA,
WpDsbA1, and BdbD (37, 135, 192).
VI. Virulence-Associated Substrates of DsbA
The DsbA–DsbB oxidative protein folding system plays an
important role in bacterial virulence. DsbA catalyzes the
correct folding of many bacterial virulence factors, including
proteins associated with adhesion (e.g., fimbrial proteins),
host cell manipulation (e.g., toxins) and cellular spread (e.g.,
flagella) (92). In general, mutants defective in the DsbA–DsbB
oxidative pathway are either directly or indirectly altered in a
range of pathogenicity-associated phenotypes and display
reduced fitness or attenuated virulence in animal infection
models (12, 14, 26, 27, 35, 139, 143, 154, 169, 204, 227). Here we
summarize the role DsbA plays in the correct folding and
function of a selection of bacterial virulence factors.
A. Chaperone-usher fimbriae
Fimbriae (also referred to as pili) are long polymeric hair-
like organelle structures that typically extend*1 mm from the
bacterial surface. Fimbrial adhesins normally recognize spe-
cific molecular motifs in a lock-and-key fashion; they there-
fore enable the bacterium to be targeted to a specific surface
and thus determine tissue tropism. Gram-negative bacte-
ria produce many different classes of fimbriae, with one of
the best studied being fimbriae that are assembled by the
chaperone–usher-dependent pathway (164, 178, 184, 195,
215). In this pathway, the fimbrial subunits are secreted into
the periplasm via the general secretory system. From there,
two specific accessory proteins are required for biogenesis: a
periplasmic located chaperone and an outer membrane lo-
cated usher. The chaperone protein binds to individual sub-
units, protects them from polymerization and targets them to
the usher. In turn, the usher protein acts as an assembly
platform for organelle biogenesis and coordinates the poly-
merization of structural components of the fimbriae.
One of the best characterized fimbriae synthesized via the
chaperone–usher pathway is P fimbriae from UPEC. P fim-
briae are comprised of six subunit proteins arranged into two
distinct components: a rod structure comprising more than
1000 copies of the PapA major subunit protein and a tip fi-
brillum comprising the PapG adhesin as well as other adaptor
proteins (101, 102). In UPEC, EcDsbA is required for the PapD
chaperone to adopt its native conformation and bind to P
fimbrial subunits in the periplasm (Fig. 13); deletion of
EcDsbA results in an inability to assemble functional P fim-
briae (112). PapD has an immunoglobulin-like structure and
contains a single intramolecular disulfide bond that is formed
between two cysteine residues located near the carboxyl ter-
minus. In the absence of PapD, the unbound fimbrial subunit
proteins do not fold properly and form aggregates that are
targeted for degradation by the DegP protease in the peri-
plasm (13). The P fimbrial adhesin PapG, which recognizes
carbohydrate moieties on the surface of host cells in the uri-
nary tract (129), also requires EcDsbA for the formation of a
disulfide bond in its tertiary structure (112).
PapD is representative of a chaperone subfamily that is
responsible for the assembly of rod-like fibers of varying
width and helical symmetry (103). The cysteine residues that
form the disulfide bond in PapD are also conserved in two
other chaperones from this subfamily, both of which are
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found in the uropathogen Proteus mirabilis. This includes the
MrpD chaperone (which coordinates the production of
Mannose-resistant Proteus-like [MR=P] fimbriae) and the
PmfD chaperone (which coordinates the production of P.
mirabilis fimbriae [PMF]) (103). In P. mirabilis, a dsbA deficient
strain produced by signature-tagged mutagenesis lacked ex-
pression of MR=P fimbriae (27), suggesting PmDsbA may be
required for the folding of the MrpD chaperone in a manner
analogous to that observed for PapD. A second chaperone
subfamily has also been described (103). Members of this
chaperone subfamily are associated with the production of
short adhesins or very thin fibers that coil up as an amorphous
mass on the cell surface (e..,g CS3 pili, aggregative adherence
fimbria I) (103). These chaperones contain two conserved
cysteine residues separated by approximately 30 residues in
the amino terminal region, and are predicted to form a dis-
ulfide bond. Although not yet demonstrated experimentally,
it is likely that DsbA proteins are responsible for the correct
folding of these chaperones.
B. Type 4 fimbriae
DsbA is associated with the production of fimbriae be-
longing to the type 4 class. Type 4 fimbriae are long, thin,
flexible filaments that mediate bacterial adhesion to target
tissues and a type of movement referred to as twitching mo-
tility (170). In the case of enteropathogenic E. coli (EPEC),
EcDsbA is required for the formation of a single in-
tramolecular disulfide bond in the BfpA major subunit of
Bundle forming pili (Bfp) (214, 230). Similarly,N. meningitidis,
the causative agent of cerebrospinal meningitis, utilizes at
least one of two membrane-bound NmDsbA paralogues for
the biogenesis of functional type 4 pili (203). In V. cholerae, the
toxin co-regulated pilus (Tcp) is an essential colonization
factor and VcDsbA (TcpG) is required for the assembly of
functional pili (169). Type 4 pili-mediated twitching motility
in P. aeruginosa requires PaDsbA as this phenotype is abol-
ished in a P. aeruginosa dsbA mutant (14).
C. Intimin, an outer membrane adhesin
Intimins are large (*95 kDa) outer membrane adhesins
produced by some pathotypes of E. coli that can cause disease
in both humans and animals through the formation of at-
taching and effacing (A=E) intestinal lesions (63). Intimin
mediates the intimate attachment of bacteria to the host cell
membrane, which is a prerequisite for A=E lesion formation
and is thus a key virulence factor of these enteric pathogens
(68). Intimins contain two distinct regions that define their
structural and functional properties. The highly conserved N
region is responsible for anchoring the protein in the outer
membrane. The C region is less well conserved and forms the
surface-exposed receptor binding part of the protein. In EPEC,
it has been demonstrated that EcDsbA catalyzes the formation
of a disulfide bond in the D3 lectin-like domain of the C region
(22). This suggests that this domain is at least partially folded
in the periplasm prior to its translocation across the outer
membrane and provides further evidence to support the role
of EcDsbA in the correct folding and function of important
bacterial virulence factors.
D. Flagella
Flagella are complex cell surface organelles that mediate
bacterial motility. The mutation of either dsbA or dsbB results
in a nonmotile phenotype due to the inability to produce
functional flagella in many different bacteria including E. coli
(26, 41, 92), S. enterica (1, 77, 206), P. mirabilis (27), Erwinia
carotovora subsp. atroseptica (35), Burkholderia cepacia (86), and
Campylobacter jejuni (169). The role of the Dsb system in fla-
gellar biosynthesis has been best characterized in E. coli,
where EcDsbA catalyzes the formation of an intramolecular
disulfide bond between two cysteine residues in the FlgI fla-
gellar P-ring motor protein (41; Fig. 14). The major structural
component in the flagella organelle, FliC, is not integrated into
the basal apparatus in the absence of correctly folded FlgI (95).
E. Toxins, secreted enzymes,
and antimicrobial peptides
Some pathogenic bacteria secrete toxins and enzymes such
as proteases to manipulate, damage, and even kill host cells.
In some cases, these secreted virulence factors require Dsb
enzymes for their correct folding and function, demonstrating
a role for the Dsb system in host–pathogen interactions. One
well-characterized example is illustrated by the role of DsbA
in the correct folding and functional assembly of AB5 toxins
FIG. 13. The role of EcDsbA in the biosynthesis of P
fimbriae. The adhesion of UPEC to epithelial cells of the
urinary tract is mediated by P fimbriae. EcDsbA catalyzes
the formation of a disulfide bond in the PapD chaperone,
which is essential for P fimbrial biogenesis. P fimbrial pro-
teins are transported across the inner membrane (IM) via the
general secretion pathway (depicted as Sec). The PapC usher
protein inserts into the outer membrane (OM) and acts as a
scaffold for the synthesis of the fimbrial organelle, which is
made up of a rod structure comprising more than 1000 copies
of the PapA major subunit protein and a tip fibrillum com-
prising adaptor proteins (PapK, PapE, and PapF) as well as
the tip-located PapG adhesin. The system is depicted in a
simplified format to highlight the specific role of EcDsbA
and is not drawn to scale.
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such as cholera toxin from the enteric pathogen V. cholerae
(169), pertussis toxin from the respiratory pathogen Bor-
detella pertussis (196), and heat-labile enterotoxin from en-
terotoxigenic E. coli (222, 228). Pertussis toxin represents
arguably the most complex structure and is assembled from
six subunits containing 11 intramolecular disulfide bonds
(42). In V. cholerae, mutation of dsbA affects the secretion of
cholera toxin A subunit and other proteases (169). Protease
production, and multi-drug resistance, in the opportunistic
lung pathogen B. cepacia also requires the BcDsbA-DsbB sys-
tem (86).
Many Gram-negative pathogens use the type II secretion
pathway to secrete enzymes that contribute to their ability to
cause disease. Some of these enzymes represent specific sub-
strates for DsbA. In P. aeruginosa, PaDsbA catalyzes the for-
mation of two intramolecular disulfide bonds in the secreted
metalloprotease elastase. This imparts stability and enhanced
activity to elastase, an important proteolytic enzyme that
contributes to the virulence of P. aeruginosa during lung in-
fection in cystic fibrosis patients (25). Lipase, another enzyme
associated with virulence and secreted by P. aeruginosa also
requires PaDsbA-catalyzed disulfide bonds for its stability
and secretion (208). In some pathogens, DsbA actually me-
diates an essential step in the structural configuration of the
type II secretion apparatus (Fig. 15). For example, secretion of
the starch-debranching enzyme pullulanase by Klebsiella
oxytoca, requires KoDsbA for the correct folding and stabili-
zation of the PulS and PulK type II secretion components (173,
185).
The soft rot erwinias are enterobacterial pathogens that
cause economically significant disease in plants. Erwinia
species phytopathogens secrete multiple virulence factors via
the type II secretion system (also referred to as theOut system)
that lead to the degradation of plant tissue. Some of these
secreted enzymes, such as cellulase, endopolygalacturonase,
and multiple pectate lyases, represent specific substrates of
DsbA (190, 210). In the potato pathogen E. carotovora subsp.
atrosceptica, DsbA (ErcDsbA) is required for the proper pro-
duction of almost all secreted virulence factors (35). Further-
more, mutation of the dsbA gene compromised several
virulence-related phenotypes, including motility, quorum
sensing, and degradation of plant tissue. Transcriptome
analysis of an E. carotovora subsp. atrosceptica dsbA mutant
revealed that ErcDsbA inactivation alters the expression of
multiple genes; the authors postulated this may occur via the
FIG. 14. The role of EcDsbA in the biosynthesis of fla-
gella. EcDsbA catalyzes the formation of a disulfide bond
essential for the correct folding of the FlgI protein of bacterial
flagella. Indicated are the inner membrane (IM) located basal
body component, the FlgI P-ring motor protein, and the ex-
ternal hook and filament components. The system is de-
picted in a simplified format to highlight the specific role of
EcDsbA and is not drawn to scale. OM, outer membrane.
FIG. 15. The role of KoDsbA in type II secretion. The type
II secretion system of K. oxytoca is depicted schematically
with the three major components indicated: the inner mem-
brane (IM) platform, the pseudopilus structure that spans
both membranes, and the outer membrane (OM) secretin
complex (174). KoDsbA catalyzes the formation of a disulfide
bond in the PulS lipoprotein (which is required for the cor-
rect insertion of the secretin into the OM) as well as the PulK
protein (which is thought to be located at the base of the
pseudopilus structure). In type II secretion, proteins are ini-
tially translocated across the IM by the general secretory
pathway (depicted as Sec) and then across the OM by the
type II secretion system. The system is depicted in a sim-
plified format to highlight the specific role of KoDsbA and is
not drawn to scale.
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pleiotropic effects of a regulator(s) responsive to periplasmic
redox status and=or the presence of misfolded proteins (35).
Taken together, ErcDsbA therefore exerts its effect on viru-
lence factor production in E. carotovora subsp. atrosceptica at
multiple levels, including protein folding and stability, tran-
script abundance, and protein secretion.
The Gram-positive organisms B. subtilis and Streptococcus
thermophilus require DsbA to enhance their survival in some
environments (48, 59). These bacteria use the DsbA homo-
logues BdbB (from B. subtilis) or BlpGST (from S. thermophilus)
for the production of functional antimicrobial peptides (lan-
tibiotic sublancin 168 and bacteriocin thermophilin 9, re-
spectively). These antimicrobial peptides enhance the fitness
of the producer organism by eliminating competition for
nutrients. DsbA-dependent bactericidal activity has also been
demonstrated for some strains of P. aeruginosa (166).
F. Type III secretion
Some bacterial pathogens employ a Type III secretion sys-
tem (T3SS) to inject effectors (bacterial virulence proteins that
modulate eukaryotic cell pathways) into host cells (34, 67).
The T3SS apparatus is comprised ofmore than 20 proteins and
consists of a basal body anchored in the bacterial membrane
linked to a needle that extends from the bacterial surface. One
key component of the T3SS apparatus is the secretin, an in-
tegral outer membrane protein that forms a stable oligomeric
structure consisting of 12 to 14 subunits with a ring-like ap-
pearance (20). DsbA is required for the correct folding of the
T3SS secretin complex in Yersinia pestis (111), enteropatho-
genic E. coli (158), S. flexneri (218), and S. typhimurium (157;
Fig. 16).
Yersinia pestis, the causative agent of plague, possesses a
plasmid-encoded T3SS that injects a set of effector proteins
known as Yops (Yersinia outer proteins) into the cytosol of
host cells. Y. pestisDsbA (YpDsbA) catalyzes the formation of
two intramolecular disulfide bonds in the YscC secretin. Y.
pestis dsbA mutants are defective in Yop effector protein
translocation due to the incorrect folding of YscC (111).
Similarly, DsbA also catalyzes the formation of an in-
tramolecular disulfide bond in the SpiA outer membrane se-
cretin of the intracellular pathogen S. typhimurium.
S. typhimurium dsbA mutants are affected in effector protein
secretion and display attenuated virulence in a mouse infec-
tion model (157). P. aeruginosa dsbA mutants are also affected
in type III secretion (14, 40), however the precise molecular
mechanism by which this occurs is unknown.
The intracellular pathogen S. flexneri requires DsbA
(SfDsbA) for oxidative folding of the T3SS Spa32 secretin
(155). S. flexneri employs a T3SS to secrete Ipa proteins that
trigger a series of signaling pathways that lead to invasion as
well as intra- and inter-cellular spread (8). Mutations in dsbA
result in defective Ipa secretion and thus affect these processes
(8, 218).
G. Role of DsbA paralogues in bacterial pathogenesis
In recent years, it has become apparent that there is sig-
nificant diversity among bacterial Dsb systems (49). Some
bacterial species encode multiple DsbA paralogues, often
with different substrate specificity. For example, the UPEC
strain CFT073 contains two Dsb systems, the prototypic
DsbA–DsbB system, and a second DsbL–DsbI system (73).
DsbL is an oxidoreductase that catalyzes the formation of a
disulfide bond in the periplasmic located enzyme arylsulfate
sulfotransferase (73). DsbL can also catalyze disulfide bond
formation in several well-defined DsbA targets when pro-
vided in trans on a multicopy plasmid (92). However, the role
of the DsbL–DsbI system in virulence remains to be deter-
mined since a UPEC CFT073 dsbLImutant was not affected in
bladder colonization using a mouse urinary tract infection
model (92).
Neisseria meningitidis produces threeDsbAoxidoreductases,
two inner membrane-associated lipoproteins (NmDsbA1 and
NmDsbA2) and one periplasmic enzyme (NmDsbA3).
NmDsbA1 and NmDsbA2 are required for the formation of
functional type IV pili, which mediate bacterial adhesion to
human endothelial cells (203). NmDsbA1 and NmDsbA2 also
mediate the correct folding of PilQ, a protein involved in DNA
uptake. NmDsbA3, on the other hand, is not involved in either
of these functions and its specific target remains to be defined.
S. typhimurium also encodes three DsbA oxidoreductases,
namely SeDsbA, SeDsbL, and SrgA. The three proteins share
low sequence identity, have different redox properties, and
FIG. 16. The role of DsbA in type III secretion. Some
bacteria are able to manipulate host cells using effectors se-
creted by the type III secretion system. DsbA catalyzes the
formation of a disulfide bond essential for the correct folding
of the outer membrane secretin. Indicated are the inner
membrane (IM) located basal body component, the peri-
plasmic spanning inner rod, the outer membrane (OM) lo-
cated secretin, and the protruding needle component. The
system is depicted in a simplified format to highlight the
specific role of DsbA and is not drawn to scale.
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display some degree of redundancy with regards to their tar-
get specificity (77, 143).
VII. Conclusions and Perspectives
Analysis of current literature on DsbA proteins indicates
that the prototypical organism E. coli seems to be an incom-
plete model for oxidative protein folding, though it does
represent one data point on a spectrum of bacterial oxidative
folding systems. For example, the combined oxidative and
isomerase machineries of E. coli are not standard in bacteria.
On the other hand, the DsbA–DsbB system is distributed
across many bacteria, and probably does represent a reason-
ably standard system for oxidative folding in Gram-negative
bacteria. Having said that, there is considerable variability in
DsbA–DsbBmachineries; the Gram-negative g-Proteobacteria
appear to take a somewhat modular approach by sometimes
encoding multiple DsbA homologues or on occasion encod-
ing an entire additional paralagous DsbL–DsbI system with a
specialized oxidative folding role.
Similarly, although the structure determination of EcDsbA
represented an important milestone in the field, inmanyways
the structural features of EcDsbA may be the exception rather
than the rule. DsbA structures all incorporate the Thioredoxin
fold with CXXC active site, cisPro loop, and an inserted helical
domain. However, the highly kinked active site a-helix and
the extended hydrophobic groove of EcDsbA are not typical.
All other structurally characterized DsbAs have a reduced
angle in the active site helix and a truncated groove, if it is
present at all. The surface hydrophobic features of EcDsbA are
also modified considerably in other structurally characterized
DsbAs, with the surface surrounding the reactive cysteine
often being charged rather than hydrophobic. Furthermore,
DsbA structures have been reported that incorporate metal
binding sites and additional disulfides. It will be interesting to
see whether the structures of DsbB proteins from other or-
ganisms vary as much as those of the DsbAs, and to investi-
gate variability in the molecular interaction between DsbB
and DsbA proteins.
Bacterial oxidative protein folding has moved center-stage
recently, with the now overwhelming evidence that the
DsbA–DsbB system plays a key role in virulence in many
pathogenic Gram-negative organisms. The increase in anti-
biotic resistance and the dearth of novel antibiotics in the
pharmaceutical development pipeline has led to calls to
identify and validate new drug targets (24, 168). DsbA and
DsbB could represent exciting new targets because blocking
their activity will interfere with the assembly of numerous
virulence factors. However, it is not yet clear whether block-
ing virulence is a valid drug development strategy (176). In
the case of DsbA and DsbB, experiments aimed at inhibiting
these proteins after infection is established would need to be
performed to demonstrate the validity of this approach for
therapeutic development.
Substrate identification has been critical in understanding
the role of DsbA in bacterial pathogenicity. The finding
that cisPro substitution can lead to accumulation of EcDsbA-
substrate complexes is tantalizing: can the same strategy be
used to identify substrates of divergent DsbA homologues? If
so, this approach might lead to a much better understanding
of how the variation in surface charge, groove shape, and size
in DsbAs relates to substrate specificity. Nevertheless, the
recent structural data showing the binding of peptides and
other ligands to DsbAs have identified the cisPro loop, the
groove adjacent to the active site and the helical domain
surface near the active site as hot spots for substrate interac-
tion. We eagerly await new data on DsbA-substrate interac-
tions.
A final word on nomenclature: We have indicated above
that EcDsbA may not represent a complete model for inves-
tigating general features of DsbA structure and function. We
therefore suggest that in publications referring to Escherichia
coli DsbA the terminology EcDsbA be used rather than the
more general term DsbA. We have provided a possible
naming scheme for DsbAs, thoughwe recognize that this may
need further development as more bacterial genomes are
sequenced.
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Abbreviations Used
A=E lesions¼ attaching and effacing lesions
ATP¼ adenosine triphosphate
Bdbd¼ alternative name for BsDsbA
BcDsbA¼Burkholderia cepacia DsbA
Bfp¼ bundle forming pili from E. coli
BpDsbA¼Bordetella parapertussis DsbA
BsDsbA¼Bacillus subtilis DsbA
Dsb¼disulfide bond forming protein
EcDsbA¼E. coli DsbA
EcDsbB¼E. coli DsbB
EcDsbC¼E. coli DsbC
EcDsbD¼E. coli EcDsbD
EcDsbG¼E. coli DsbG
EcDsbI¼E. coli DsbL, a paralogue of E. coli DsbB
EcDsbL¼E. coli DsbL, a paralogue of E. coli DsbA
EPEC¼ enteropathogenic E. coli
ER¼ endoplasmic reticulum
ErcDsbA¼Erwinia carotovera subsp. atrosceptica
DsbA
Ero1p¼ yeast protein ‘‘endoplasmic reticulum
oxidoreductin’’
Erv2p¼ yeast protein ‘‘essential for respiration
and vegetative growth’’
FAD¼flavin adenine dinucleotide
Glyc¼ glycerol
GST¼ glutathione S-transferase
IMS¼ inter membrane space
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Abbreviations Used (cont.)
KoDsbA ¼ Klebsiella oxytoca DsbA
MIA ¼ mitochondrial machinery
for import and assembly
MK ¼ menaquinone
NeDsbA ¼ Nitrosomonas europaea DsbA
NmDsbA1 ¼ NmDsbA2 and NmDsbA3,
Neisseria meningitidis DsbA1,
DsbA2 and DsbA3
P1 ¼ first periplasmic loop
of EcDsbB
P2 ¼ second periplasmic loop
in EcDsbB
PaDsbA ¼ Pseudomonas aeruginosa
DsbA
PDB ¼ protein data bank
PDI ¼ protein disulfide isomerase
PEG ¼ polyethylene glycol
PhoA ¼ alkaline phosphatase
PmDsbA ¼ Proteus mirabilis DsbA
SaDsbA ¼ Staphylococcus aureus DsbA
ScDsbA ¼ Streptomyces coelicolor DsbA
SCOP ¼ structural classification
of proteins
SeDsbA ¼ Salmonella enterica serovar
Typhimurium DsbA
SeDsbL ¼ Salmonella enterica serovar
Typhimurium DsbL
SeMet ¼ selenomethionine
SeSrgA ¼ Salmonella enterica serovar
Typhimurium virulence
plasmid-encoded DsbA
SfDsbA ¼ Shigella flexneri DsbA
T3SS ¼ type III secretion system
Tcp ¼ toxin co-regulated pilus
from V. cholerae
TcpG ¼ alternative name for VcDsbA
TIC ¼ translocon at the inner
envelope of chloroplasts
TOC ¼ translocon at the outer
envelope of chloroplasts
TrxP ¼ Bacteroides fragilis periplasmic
thioredoxin
UPEC ¼ uropathogenic E. coli; UQ,
ubiquinone
VcDsbA ¼ Vibrio cholerae DsbA
VfDsbA ¼ Vibrio fischeri DsbA
VKOR ¼ vitamin K epoxide reductase
WpDsbA1 and WpDsbA2 ¼ Wolbachia pipientis DsbA1
and DsbA2
XfDsbA ¼ Xylella fastidiosa DsbA
YpDsbA ¼ Yersinia pestis DsbA
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